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Abstract
Physiological Correlates of Emotion Regulation in Depersonalization Disorder

by

Kai-Mosadi Monde

Advisor: Professor Victoria Luine
Depersonalization disorder (DPD), is an often debilitating DSM V psychiatric disorder
characterized by feelings of detachment from the self or others as well as emotional blunting or
numbness. Subjective and physiological evidence of decreased emotional arousal may suggest
impaired emotion regulation abilities. Deficits in emotional processing of DPD may be the result
of dysregulated cortisol and oxytocin levels, however oxytocin levels have never been assessed
in DPD. In this series of studies, we aimed to investigate the physiological correlates of emotion
regulation in depersonalization disorder. In experiment 1, DPD patients and a normal control
group subjectively enhanced and suppressed emotion to affective pictures. Compared to the
control group, the DPD group tended to be better at suppressing emotion to unpleasant pictures
and tended to modulate subjective arousal less effectively. In experiment 2, we measured heart
rate and skin conductance response while DPD patients and a healthy control group enhanced
and suppressed emotion to affective stimuli. DPD patients were better able to suppress and less
able to enhance emotion (heart rate). In experiment 3, we investigated the relationship between
cortisol and oxytocin responsivity during the Trier Social Stress Test (TSST) in DPD. The TSST
induced subjective stress in the normal control group but not in the DPD group. The control
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group also demonstrated a positive association between post-stress cortisol and decrease in
oxytocin during the 20 minute stress recovery period, an association not found for the DPD
group. However, the DPD group had higher overall cortisol levels and tended toward higher
oxytocin levels. In experiment 4, we explored the relationship between cortisol, oxytocin, and
depersonalization during recall of a personally relevant stressful event by Psychology 100 course
students. Consistent with experiment 4, post-stress cortisol was associated with a decrease in
oxytocin during stress recovery. However, depersonalization was associated with less decrease in
oxytocin during stress recovery. Taken together, these results suggest emotional blunting in DPD
is accompanied by a superior ability to suppress emotion and dysregulated hormonal responses.
DPD patients may benefit from pharmacological interventions that regulate cortisol and oxytocin
levels and therapeutic interventions that support enhancing emotion subjectively and
physiologically.
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Introduction
The aim of these studies is to investigate the neurobiological underpinnings of emotion
regulation in depersonalization disorder. Further elucidation of the neural and chemical
mechanisms which underlie detachment and emotional blunting in DPD will improve our ability
to develop therapeutic treatments that ameliorate these symptoms.

Overview of Depersonalization Disorder
Symptomology
Dissociative disorders are DSM IV psychiatric disorders which comprise disruptions in
memory, awareness/consciousness, identity, or perception, all of which are psychological
functions that are typically integrated in healthy individuals (American Psychiatric Association,
DSM IV-TR, 2000). However, persons diagnosed with these disorders have intact reality testing.
The DSM IV classifies five dissociative disorders which include dissociative identity disorder,
dissociative fugue, dissociative amnesia, depersonalization disorder (DPD) and dissociative
disorder, not otherwise specified. DPD represents a disruption in the integration of selfperceptions with the sense of self (Simeon, 2004). Depersonalized individuals feel detachment
from themselves or others, and describe feeling as if they are outsiders in their own mental
processes or bodies. Persons with depersonalization disorder feel as if they are in a dream,
movie, or fog, or feel disconnected from their body, and/or feel like they are on autopilot. Other
components of the depersonalization experience include a sense of emotional numbing or
bluntness as well as somatosensory distortions (Sierra and Berrios, 2001). Depersonalization
disorder is often accompanied by derealization-feeling detached from one’s surroundings (people
and objects) or feeling that known surroundings are actually unfamiliar (Simeon, 2004). DPD
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patients also present with high incidence of alexithymia, specifically difficulty identifying
feelings (Simeon, Giesbrecht, Knutelska, Smith, & Smith, 2009). Brief experiences of
depersonalization and transient depersonalization in response to severe trauma (e.g., accidents or
assault) are common in the general population. However, persistent or recurrent
depersonalization in conjunction with significant distress or impairment would be classified as
DPD barring the concurrent presentation of other conditions such as epilepsy, head trauma,
hallucinogen persisting perception disorder, schizophrenia, etc.
DPD is often accompanied by difficulty in focusing. Neuropsychological testing has
demonstrated impairments in attention, short-term visual and verbal memory, and spatial
reasoning while long term memory appears intact (Guralnik, Schmeidler, & Simeon, 2000).
Somatosensory distortions often reported by DPD patients include such symptoms as subjective
flattening of the 3 dimensional visual-perceptual world into two dimensions (Sierra and Berrios,
2001) which may contribute to the disruptions in attention and memory (Simeon, 2004).
Depersonalization disorder is underdiagnosed for the following reasons: 1. DPD is often
comorbid with anxiety and mood disorders and treatment often focuses on ameliorating those
symptoms without addressing the depersonalization and derealization. 2. Many clinicians are
unfamiliar with the symptomology of the disorder; the average length of time a patient seeks
treatment before receiving a diagnosis of DPD is 8 years (Simeon, Knutelska, Nelson, &
Guralnik, 2003). 3. Many patients do not disclose of their symptoms of depersonalization for
fear of being considered crazy or misunderstood (Simeon, 2004). However, consistent with other
well-known disorders, prevalence of DPD ranges from 40% to 80% of psychiatric in inpatient
population (Brauer, Hauer, & Tucker, 1970; Hunter, Sierra, & David, 2004) and 1% to 2.4% in
the general population (Ross, Joshi, & Currie, 1991; Hunter, Sierra, & David, 2004), rates
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comparable to those of schizophrenia and bipolar disorder. Although often comorbid with mood
and anxiety disorders, unlike these disorders which affect more women than men, the gender
ratio for DPD is about 1:1 (Simeon et al, 2003; Baker, Hunter, Lawrence, et al., 2003). There is
also high comorbidity of depersonalization disorder with personality disorders like borderline,
avoidant, and obsessive-compulsive personality disorders (Simeon et al., 2003).

Etiology
As early as the 1800’s and 1900’s, theorists like Charcot and Janet had hypothesized that
individuals with a predisposition for dissociation who were exposed to trauma could develop a
dissociative disorder (Hart & Worst, 1989). Later, Bowins (2004) described dissociative states as
evolutionarily adaptive, beneficial to the organism in milder states, but maladaptive when they
begin to interfere with daily function. Still others have theorized that dissociation is a defense
mechanism employed to deal with overwhelming stress and trauma. In fact, trauma, and
specifically, childhood trauma may be one risk factor for the development of depersonalization
disorder (DPD). DPD patients report a high incidence of childhood interpersonal trauma with
emotional abuse and neglect being most prevalent, however, physical and sexual abuse and
physical neglect have also been reported (Simeon et al., 2001). However, later-life traumatic
events and interpersonal stressors can also trigger DPD or further exacerbate milder forms of the
disorder (Simeon et al., 2004) Hence, Sierra (2008) hypothesized that depersonalization may be a
pervasive inhibitory cognitive and physiological response to chronic stress.
Onset of DPD may be acute or deliberate with typical DPD onset occurring in
adolescence (Simeon et al, 2003), and early onset associated with greater symptom severity
(Baker et al., 2003). Acute onset may be in response to a severe stressor or trauma, in
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conjunction with onset of another disorder such as panic disorder or depression (when the other
disorder subsides but depersonalization persists, a diagnosis of DPD is considered), in
conjunction with consumption of a controlled substance, or with no apparent precipitating factor.
However, for deliberate onset, clear memory of precipitating factors or incidents may not be
available often because onset was too early in development to recall the antecedents (Simeon,
2004). Acute onset of DPD with a temporal association of chemical use like marijuana,
hallucinogens and ecstasy suggest that drug use may trigger depersonalization disorder in some
cases (Simeon et al., 2003). Simeon (2004) proposed that the effects of these substances which
alter self-perception are interpreted as a trauma by the predisposed individual and trigger
depersonalization. Simeon also posited that these drugs may interfere with neurochemical
systems of individuals with a predisposition for depersonalization, and specifically trigger the
disorder biologically. Notably, ketamine and cannabinoids like marijuana are NMDA receptor
antagonists and have been shown to induce symptoms of depersonalization in laboratory settings
(Curran & Morgan, 2000; Szymanski, 1981).
In about one-third of patients, DPD is episodic and can last hours, days or months,
however the disorder can eventually become continuous, possibly with varying intensities over
time (Simeon et al, 2003; Baker, Hunter, Lawrence, et al., 2003). DPD can be accompanied by
severe distress and impairment. The difficulty in focusing, the feelings of being detached from
the self or others, and the emotional blunting and numbness complicate, and in severe cases,
impede work and interpersonal relationships (Simeon, 2004).

Emotion Regulation in DPD
Emotions and Emotion Regulation Defined
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Emotions arise in response to salient cues in the environment. Emotional responses can
occur immediately or only after meaning has been deducted from a situation (Gross, 2002).
Humans have evolved to utilize emotions to appraise physical and psychological threat and then
devise a response to the threat that is deemed most advantageous (e.g., fight, flight, or freeze).
Although, our emotional responses are typically appropriate given our life circumstances, there
are instances when our emotionality does not coincide with the situation. Dysfunctional
emotional responsivity occurs when our emotions are inappropriate for a situation and evidenced
by how we experience them internally (subjective emotionality) or how and when we are display
them (projective emotionality, which may include observed physical behavior as well as
physiological responses). However, subjective and projective emotionality are not mutually
exclusive; how we feel often corresponds with or even dictates what we do. Extreme examples of
displayed dysfunctional emotionality are demonstrated by psychiatric disorders such as
schizophrenia: positive symptoms of schizophrenia like hallucinations can present with
inappropriate laughter while negative symptoms like flat affect may present in response to sad
news. An example of experienced dysfunctional emotionality is evident in persons who
experience alexithymia, which encompasses an inability to identify or describe emotions. Other
psychiatric conditions are marked by variations in the magnitude of emotional responsivity.
While borderline personality disorder is known for extreme and abrupt shifts in and exasperated
presentation of both projective and subjective emotionality, symptoms of schizoid personality
disorder include emotional coldness or apathy (see American Psychiatric Association, DSM IVTR, 2000). These differences in emotional responsivity and emotional intensity have been
documented with physiological correlates both centrally (e.g., brain activity) and peripherally
(e.g., skin conductance response, heart rate measures, plasma and salivary hormone levels).
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The limbic brain comprising the emotion centers of the brain was theorized to be one of
the earliest clusters of brain structures to evolve in humans. Its purpose is to manage fight, flight,
or freeze circuitry which is an evolutionary necessity for organisms in the presence of
threatening stimuli (Newman & Harris, 2009). In humans, the structures of the limbic system
include the hippocampus (associated with memory formation), the amygdala (associated with
fear and pleasure) the insula (associated with disgust), the cingulate gyrus (associated with
autonomic functions), the nucleus accumbens, associated with pleasure and reward, the
hypothalamus (associated with hormone regulation), and the fornix, which connects the
hippocampus to the hypothalamus, the thalamus (relays signals between brain structures as well
as the spinal cord). Limbic structures are innervated by cortical structures which in turn regulate
limbic activation and facilitate sensory integration. The complex interplay of neurochemical
changes in these brain structures is perceived cognitively by the individual as emotion, often
eliciting specific behaviors.
When our emotions are inappropriate for a given situation, we try to regulate them,
curtailing our emotional responses so that they better fit the current setting (e.g., we suppress
laughing at a funny incident that occurs spontaneously during a funeral, we enhance our
excitement while watching our child’s favorite cartoon with them, and we try to maintain
enthusiasm for an interesting lecture that goes too long). The ability to accurately perceive,
name, and regulate emotions so that they are appropriate given the situation is key to mental
wellbeing. Gross (2002, p. 282) defines emotion regulation as “changes in the latency, rise time,
magnitude, duration, and offset of responses in behavioral, experiential, or physiological
domains.” Emotion regulation strategies can be conscious or unconscious, and no strategy works
for all people in all situations.
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Particular emotion regulation strategies may be utilized throughout the emotion
generative process. Gross (2002) distinguishes between antecedent-focused and responsefocused strategies. Antecedent-focused strategies are those employed prior to full activation of
the emotional response. They include situation selection (approaching or avoiding people or
situations in order to regulate emotions), situation modification (also known as problem-focused
coping: tailoring the situation in order to regulate emotions), attentional deployment (focusing on
or distracting oneself from specific aspects of the situation in order to regulate emotion), and
cognitive change (also known as reappraisal: deciding the meaning of a situation or changing
one’s outlook prior to full onset of the emotion). Response-focused strategies involve response
modulation: changing the emotional response after an emotion has been elicited. Response
modulation can affect experiential (subjective), behavioral, and physiological components of
emotion.
Antecedent-focused and response-focused strategies can affect subjective and projective
emotionality differently. Gross (1998) found that while the antecedent-focused strategy of
cognitive reappraisal to down-regulate emotions decreases subjective emotion, emotionexpressive behavior, and physiological responsivity (heart rate, temperature, and skin
conductance), using the response-focused strategy of suppression (controlling ones outer
appearance so that others cannot detect your emotion) decreases emotion-expressive behavior
but increases subjectively experienced emotion and physiological responsivity. Additionally,
compared to reappraisal, emotional suppression was associated with decreased memory for
situation details and was generally associated with reported poorer social support, social support
coping, and social likability (Gross, 2002).
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There may be sex differences in emotion regulation ability. For instance, McRae et al.
(2008) administered a cognitive reappraisal task to participants while they underwent functional
magnetic resonance. The authors found that compared to women, men showed less increases in
prefrontal regions that are associated with reappraisal, greater decreases in the amygdala
activation and less ventral striatal activity (an area associated with reward processing). The
authors posited that results may indicate that for men, cognitive regulation requires less effort
due to greater autonomic emotion regulation or that women use more positive emotions for
reappraising negative emotions which, in turn, require more cortical resources.

Emotional processing in DPD
Evidence suggests impairment in emotional processing for DPD patients. DPD patients
show high levels of alexithymia and may experience emotional blunting (a dampening of the
emotional experience) or numbness as well as an emotional disconnection from their loved ones
(Sierra and Berrios, 2001), both delineating a dysfunctional experience of emotion. DPD
patients have also expressed feeling less aroused by unpleasant pictures (Sierra, Senior, Dalton,
McDonough, Bond, et al.,2002) and have rated emotional pictures as less intense (Sierra, Senior,
Phillips, & David, 2006; Phillips, Medford, Senior, Bullmore, Suckling, et al., 2001) than healthy
controls and anxiety groups indicating a decreased magnitude of emotions. Correspondingly
physiological measures assessed in these studies indicate a decrease in neural response while
viewing emotional stimuli: lower amplitudes in skin conductance response were found for
unpleasant pictures and disgusted faces in the DPD groups compared to controls and an anxiety
group (Sierra et al., 2002; 2006). Early case studies have also indicated decreases in skin
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conductance that corresponded to symptoms of depersonalization (Lader and Wing, 1966; Lader,
1975).
In functional Magnetic Resonance Imaging studies, DPD patients have shown differences
compared to controls in the activity of brain areas associated with emotional processing. DPD
patients exhibit increased right ventral prefrontal cortex (PFC) and decreased insula activation in
response to aversive pictures (Phillips, et al., 2001). Additionally, Lemche, Anilkumar,
Giampietro, Brammer, Surguladze, et al. (2008) found that when presented with faces consisting
of happy and sad expressions of varying intensities, DPD patients showed decreased activity in
the right hypothalamus/semilunar gyrus in response to happy faces and in the right
amygdala/uncinate gyrus in response to sad faces, activity which negatively correlated with
expression intensity. PFC activation was also associated with decreased autonomic response in
this study. While the insula is a limbic area associated with the neural response to disgust,
negative mood, and unpleasant visceral sensations like pain, the PFC has been associated with
emotion regulation (Phan, Fitzgerald, Nathan, Moore, Uhde et al., 2005; Dolcos, Kragel, Wang,
L., & McCarthy, 2006). Taken together, these studies suggest the PFC is playing an active role in
the inhibition of the emotional response of limbic areas in the DPD group and may underlie the
blunting of both positive and negative emotions found in DPD.
Active regulation of the emotional response has never been investigated in DPD patients.
However, the decreased subjective and projective arousal to affective stimuli found in the
disorder may suggest a greater ability to suppress but a lesser ability to enhance emotion as
evidenced by subjective report and physiological measures like heart rate and skin conductance
response.
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Stress
Stress and the hypothalamo-pituitary adrenocortical (HPA) axis
The literature well documents the negative effects of chronic stress on both physical and
mental health. Thus, stress influences physical disorders like heart disease, diabetes and stroke. It
may also be a precipitating factor for mental disorders like schizophrenia and depressive and
anxiety disorders. Stress has been defined as any situation where demands are perceived to
exceed personal resources (Lazarus, 2006). Thus, stress is a subjective experience, relevant to
each individual, and a given stressor may affect two individuals differently. The perception of
stress facilitates a cascade of cognitive and neuroendocrine changes in the body for purposes of
adapting to the stressor.
Cortisol (hydrocortisone) is one hormone released in response to stress (see Buckingham,
2006 for review). It is a lipid based steroid hormone, specifically a glucocorticoid that impacts
all bodily systems. Cortisol is synthesized from cholesterol in the zona fasciculate of the adrenal
glands. Two corticosteroid receptors have been identified: the mineralocorticoid receptor and
glucocorticoid receptor. While mineralocorticoid receptors are localized primarily in the kidneys
and other tissues involved with sodium/potassium balance, glucocorticoid receptors are widely
distributed throughout the body with receptor concentrations fluctuating depending on cell cycle
stage and environmental factors (like stress). While for humans, the predominant glucocorticoid
produced is cortisol, rats produce corticosterone while pigs and dogs produce both.
A major function of cortisol is to foster release of amino acids and fats from cells in order
for them to be used as energy and to be synthesized into new compounds, fostering
gluconeogenesis: the generation of glucose from non-carbohydrate carbon substrates such as
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lactate and glycerol (Levine, Zagoory-Sharon, Feldman, Lewis, & Weller, 2007). Cortisol also
plays a role in suppressing the immune system which includes its anti-inflammatory effects.
There is a diurnal pattern of pulsatile cortisol release which is associated with normal
development (e.g., lung development) and homeostasis. In the diurnal clock of humans, cortisol
levels peak early prior to waking, spike by 50 – 100% within the first 30 to 45 minutes of waking
(the awakening cortisol response) and gradually decrease throughout the day. These changes in
cortisol levels correspond to the pulsatile release of CRH and ACTH which also decreases
throughout the day (see Levine et al, 2007 for review).
The stress response release of cortisol governed by the hypothalamo-pituitary
adrenocortical (HPA) axis overlaps the pulsatile diurnal clock of cortisol (Buckingham, 2006).
The HPA axis functions thusly: in response to a stressor, the cells in the periventricular
hypothalamic nucleus (PVN) of the hypothalamus secrete corticotrophin releasing hormone
(CRH) which travels via the hypophysealportal blood vessels to the anterior pituitary prompting
secretion of adrenocorticotropic hormone (ACTH). ACTH then stimulates the release of cortisol
from the zona fasciculate of the adrenal glands. The HPA axis functions with a negative
feedback loop: elevated cortisol levels suppress CRH and ACTH release which inevitably
suppresses the release of cortisol. Activation of the HPA axis is influenced by projections to the
medial PVN which typically arrive from first and second order inputs of somatic nociceptors
(pain perception), visceral afferents (neurons of the autonomic nervous system), or humoral
sensory pathways (concerning immunity) suggesting a reflexive function of the PVN in the HPA
axis (Herman et al, 2003) .
Release of other neuropeptides work in conjunction to the HPA axis in regulating cortisol
(see Herman et al., 2003 for review). The nucleus of the solitary tract in the brainstem also
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projects to the PVN, releasing norepinephrine (NE) and epinephrine. However, evidence
suggests that the effects of norepinephrine on the PVN may be mediated by glutaminergic
interneurons, and high levels of NE may have inhibitory effects on the release of ACTH and
thus, on cortisol release. Arginine Vasopressin (AVP) is produced by the
hypothalamic supraoptic nuclei (SON) and paraventricular nuclei (PVN) and released by the
posterior pituitary gland and also works in conjunction with CRH to enhance the effects of
ACTH (AVP also inhibits release of oxytocin). Serotonin in the PVN also stimulates production
of cortisol, although few projections originating from the raphe nucleus are found in the PVN.
Dopaminergic cells originating from the thalamus also innervate the PVN and dopamine is also
known to activate the HPA axis. Projections emanating from other regions of the hypothalamus
innervate the PVN as well and are primarily GABAergic although some glutamatergic
innervations are also found, indicating the complexities of regulation of the HPA axis as well as
highlight the specificity of the stress response as different cells centers of the HPA axis are
activated depending on the stressor. For instance, in rodents NMDA and AMPA/kainate receptor
antagonists inhibit ACTH responses to immobilization, but not footshock or ether. The PVN also
receives innervations from the posterior hypothalamus which in turn receives inputs from the
limbic forebrain which may indicate the role of the limbic system in initiating and regulating the
stress response. Other limbic structures such as the hippocampus, the prefrontal cortex, and the
amygdala influence the stress response indirectly via intermediate innervations to the medial
PVN.
Jankord & Herman (2009) describe two ways in which the HPA axis is activated. A
reactive stress response is a reflexive response to a physical challenge and results from direct
innervations of the PVN by peripheral neurons like nociceptors, Conversely, in the absence of
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tangible threat activaction of the HPA axis can be an anticipatory response initiated by innate
organismic programing like instinctual fear or by psychogenic stressors like memories.
Anticipatory responses result from innervations emanating from the limbic system. Chronic
stress enhances both basal HPA function and stress reactivity indicating that there are
mechanisms to bypass negative feedback inhibition. Limbic structures such as the hippocampus,
the prefrontal cortex, and the amygdala influence the anticipatory stress response indirectly via
intermediate innervations to the medial PVN, while the hippocampus and prefrontal cortex
inhibit response to anticipatory stressors, the amygdala facilitates the stress response (Herman et
al, 2003).
Cortisol is found in the bloodstream in both free and bound forms and has a half life of
about 80 minutes. In plasma, cortisol is primarily bound to corticosteroid-binding globulin
(CBG) but also to albumin while the remainder is free. The molecular weight of free cortisol is
low (about 362 Da), allowing for passive diffusion of cortisol across capillary walls. The free
hormone hypothesis posits that only free cortisol is biologically active. However, Tait and
Burstein (1964) argue that since cortisol has a weak affinity for albumin, cortisol loosely bound
to albumin should also be considered as free. The amount of free cortisol catabolized by the liver
via hepatic uptake is three times that of free cortisol found in plasma. Plasma cortisol levels less
than 80nM at 9:00 AM may indicate inadequate adrenal function while levels greater than
300nM at that time may exclude such deficiency (see Levine et al. 2007 for review). However,
the awakening cortisol response as measured in saliva is not always reliable.
In contrast to plasma, salivary cortisol is primarily free cortisol that has passively
diffused from the blood into saliva glands. Salivary cortisol represents 50-70% of serum free
cortisol levels. However, correlations between salivary cortisol and total plasma cortisol levels
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range between r=0.71 and r=0.96, thus lending salivary cortisol an effective substitute for free
plasma cortisol, despite diurnal differences between the two.(See Levine et al., 2007 for review).
There are sex differences in cortisol levels and stress. Cortisol is generally found in
higher levels in women than in men and females show greater HPA reactivity particularly during
the proestrus day of the estrus cycle compared to males while testosterone inhibits HPA response
to stress. (Herman et al 2003). Dedovic et al. (2009) document greater deactivation of the
prefrontal cortex and hippocampus for men compared to women in response to a social stressor.
For the task, cerebral blood flow in the hippocampus and perceived stress for the task were
positively correlated for women but negatively correlated for men. However, in these studies,
stage of menstrual cycle for the women was not recorded. Cortisol has been shown to be lowest
during the follicular phase, highest during ovulation, and then decrease but still remain higher
during the luteal phase compared to the follicular phase (Gennazzi et al., 1975; Walder, Statucka,
Daly, Axen, Haber, 2012). Basal cortisol levels in women in the early follicular phase have been
shown to be lower than men (Walder et al., 2012). Additionally, in response to the TSST, while
there is no difference in stress reactivity between women in the luteal phase of their cycle and
men, men have greater cortisol reactivity than women in the follicular phase of their cycle, and
there is no difference between women in the follicular stage and women using oral contraception
(Kirschbaum et al., 1999).

The HPA Axis and Depersonalization Disorder
Research findings are inconsistent with regard to cortisol levels in DPD patients. In a
pilot study, Simeon et al (2001) found that when they controlled for depression, the DPD group
had higher basal plasma cortisol levels than a control group. In another study, Simeon et al.
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(2007) found higher basal urinary cortisol levels in dissociative patients compared to controls. In
the same study, the DPD group with comorbid lifetime major depression had significantly higher
urinary cortisol levels than healthy controls and a tendency toward higher urinary cortisol levels
compared to non-depressed DPD participants. The study of Stanton et al. (2001) diverges from
these findings: they indicated salivary cortisol levels of DPD patients were lower over a 24 hour
period than those of patients with major depressive disorder but did not differ from healthy
controls. However, taken together, the results of these studies are consistent with previous
research that found higher cortisol levels in depressed patients than controls (Hein et al, 2001)
and may suggest that depression is a mediating factor of potentially elevated cortisol levels in
DPD patients.
Few studies have documented the effects of acute neurochemical stressors in DPD.
However, two studies used dexamethasone administration to investigate suppression of the
physiological stress response in DPD. Dexamethasone is a glucocorticoid receptor antagonist
with a higher affinity for the glucocorticoid receptor than cortisol. The binding of dexamethasone
to the glucocorticoid receptor instigates suppression of the Hypothalamus-Pituitary-Adrenal
(HPA) axis. DPD patients have demonstrated higher plasma cortisol levels following
dexamethasone administration (Simeon et al, 2001) as well as significant resistance to and faster
escape from dexamethasone suppression (Simeon et al., 2007), suggesting that depersonalized
individuals are more resistant to HPA axis suppression than healthy controls.
There are also few studies investigating the response of depersonalized individuals to
acute social stressors. In one study, although DPD patients rated the Trier Social Stress Test
(TSST) as significantly more stressful than a control group but less stressful than a Posttraumatic
stress disorder (PTSD) patient group, plasma cortisol reactivity in response to the TSST did not
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differ between the groups (Simeon et al., 2007). However, in another study utilizing
undergraduate students, both subjective stress following the TSST and cortisol reactivity were
positively related to dissociation severity (Giesbrecht et al, 2007).
Norepinephrine (NE) is also important in the regulation of the HPA axis. DPD patients
have been shown to have altered levels of NE. Simeon et al. (2003) found elevated levels of
urinary NE in DPD patients compared to controls when they controlled for anxiety. However,
there was an inverse relationship between NE levels and depersonalization severity which
suggests that some mechanism involved in DPD also results in some inhibition of NE. While low
levels of NE are associated with depressed mood, increased levels of NE are associated with
anxiety as well as an inability to recognize negative emotion (Harrison, Morgan, & Critchley,
2010). Thus, in addition to increased cortisol levels, elevated NE levels in DPD patients may
correspond with elevated levels of anxiety and alexithymia typically seen with the disorder,
however more severe cases of depersonalization may show less elevated NE levels,
corresponding with often comorbid symptoms of depression.

Oxytocin and the HPA axis
Oxytocin (OT) is a neurohypophysial peptide hormone closely related in structure to
arginine vasopressin. It is produced in the magnocellular neurons of the hypothalamic supraoptic
nuclei (SON) and paraventricular nuclei (PVN) of the brain, and stored in the neurohypophylis
of the posterior pituitary where it may be released into the bloodstream, or released from OT
fibers of the hypothalamus that project to a multitude of brain areas including limbic structures
where it acts as a neurotransmitter or neuromodulator (Gimpl & Fahrenholz, 2001). OT is also
produced in other parts of the body such as the gastrointestinal tract, heart, testes and uterus
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(Kiss and Mikkelsen, 2005) and is found in elevated concentration in the adrenal glands (Gimpl
& Fahrenholz. 2001) suggesting that oxytocin may play a direct role in regulation of cortisol
levels.
OT receptors are well distributed throughout the human brain with highest concentrations
found in the substantia nigra and globus pallidus, the anterior cingulate, and the medial insula,
but not in the hippocampus, amygdala, entorinal cortex, or olfactory bulb (Marazziti and
Dell’Osso, 2008), suggesting a targeted role of OT in emotion. Estradiol, progesterone, and
testosterone facilitate OT receptor binding while castration reduces it (Gimpl & Fahrenholz,
2001), and in women, OT levels are higher during the follicular and ovulatory phases compared
to the luteal phase (Salonia, Nappi, Pontillo, Daverio, Smeraldi, Briganti, et al., 2005; Shukovski,
Healy, & Findlay, 1989). Hence, gonadal hormone levels may greatly influence OT action. OT
release follows a circadian rhythm with cerebral spinal fluid levels peaking at midday (McCarthy
& Altemus, 1997). Although salivary and plasma OT levels have been shown to be correlated
(Grewen, Davenport, & Light, 2010), OT levels in the CSF are not related to plasma OT levels
(Kagenbauer, Martin, Schuster, Blobner, Kochs, & Landgraf, 2013), and OT cannot readily
traverse the blood-brain barrier (Gimpl & Fahrenholz, 2001).
Oxytocin influences a multitude of systems within the body. It is released in response to
nipple and genital stimulation, suckling, estrogen administration, oral contraceptive use, and
pregnancy (McCarthy and Altemus, 1997), and the effects of OT on sexual and reproductive
behavior have been well documented. OT release is also associated with decreased blood
pressure, and corticosterone levels in rats, as well as increased insulin, all actions which are
counter to the HPA stress response (Gimpl & Fahrenholz, 2001). Notably, intravenous infusion
of OT shows a suppressive effect on the HPA axis in humans (Legros, 1984; Chiodera, & Coiro,
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1987), and OT has also been shown to attenuate the cortisol surge in response to physical stress
(Cardoso, Ellenbogen, Orlando, Bacon, & Joober, 2012). As well, subchronic intranasal
administration of OT has also been shown to attenuate the HPA axis response to social isolation
in monkeys (Parker, Buckmaster, Schatzberg, & Lyons, 2005). Additionally, cortisol inhibits
both the hypothalamus and the pituitary gland leading to reduced secretion of AVP. Conversely,
cortisol administration in humans has also been shown to increase oxytocin (Tops, van Peer, &
Korf, 2007) which has been related to decreased recall of unpleasant stimuli (Tops, BursmanPiglman, Boksem, Wijers, & Korf, 2012). These findings indicate that cortisol and oxytocin
work in tandem in regulating the stress response.
Cognitive effects of OT have also been shown. Oxytocin is known to decrease learning
and memory (Gimpl & Fahrenholz, 2001) but facilitate social bonding (see McCarthy &
Altemus, 1997 for review). Increased OT levels are associated with generosity (Morhenn et al.,
2008) and trust (Kosfeld, Heinrichs, Zak, Fischbacker, & Fehr, 2005). OT also induces satiety,
reducing feeding in rats (Gimpl & Fahrenholz, 2001). However, oxytocin administration seems
to decrease emotionality in some subjects. OT reduces anxiety and shows anti-depressive effects
on rats (Arletti & Bertolini, 1987). OT administration and social support individually reduce
anxiety, and in conjunction decrease cortisol levels during the TSST (Heinrichs, Baumgartner,
Kirschbaum, & Ehlert, 2003). Intranasal OT administration has also been shown to attenuate the
increased cortisol response to a social stressor in persons with impaired emotion regulation
abilities (Quirin et al., 2011) and borderline personality disorder (Simeon, Bartz, Hamilton,
Crystal, Braun, Ketay, et al., 2011). OT administration has also been shown to impede trust in
Borderline Personality Disorder patients (Bartz, Simeon, Hamilton, Kim, Crystal, Braun, et al.,
(2011). Correspondingly, activation of the right amygdala to positive and negative stimuli has
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also been shown to decrease with intranasal oxytocin (Domes, Heinrichs, Gläscher, Büchel,
Braus, & Herpert, 2007).
Dysregulated OT levels have been found in several psychiatric disorders but findings are
conflicting. Although lower OT levels during pregnancy have been associated with post-partum
depression (Skrundz, Bolten, Nast, Hellhammer & Meinlschmidt, 2011), increased OT levels
may be associated with depression (Parker, Kenna, Zeitzer, Keller, Blasey, Amico, et al., 2010;
Cyranowski, Hofkens, Frank, Seltman, Cai, & Amico, 2008). Elevated OT levels in
cerebrospinal fluid have been associated with obsessive compulsive disorder in one study
(Leckman, Goodman, North, Chappell, Price, Pauls, et al., 1994) but not another (Altemus,
Jacobson, Debelles, Kling, Pigott, Murphy, et al. 1999), and may be equated to increased
grooming behavior found in animals with OT microinjection since excessive grooming in
animals is considered a model for compulsion (Marazziti and Dell’Osso, 2008). Consistent with
the effects of OT on feeding in rats, decreased levels of OT in cerebrospinal fluid of eating
disorder patients have been observed (Demitrack, Lesem, Listwak, Brandt, Jimerson, & Gold
PW, 1990). OT levels return to normal when eating disorder patients return to normal body
weight. An inverse relationship between OT levels in cerebrospinal fluid and negative symptoms
of schizophrenia has also been found (Sasayama, Hattori, Teraishi, Hori, Ota, Yoshida, et al.,
2012). Decreased OT levels have also been found in autistic individuals, and long term
administration increases social cognition in autism (Anagnostou, Soorya, Chaplin, Bartz,
Halpern, Wasserman, et al., 2012). Plasma OT levels are also decreased in women with
borderline personality disorder (Bertsch, Schmidinger, Neumann, Herpertz, 2013). A recent
study has indicated that increased levels of OT may be associated with dissociation (Seng,
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Miller, Sperlich, van de Ven, Brown, Carter, et al., 2013), however OT levels have never been
measured in DPD.
Although OT has been shown to suppress ACTH and cortisol release, OT secretion in
response to psychosocial stress is not as clear. Two studies have found that psychosocial stress
increases oxytocin in humans. Sanders et al. (1990) showed that uncontrollable noise elicited
increased OT in emotional women but not men. Pierrehumbert et al. (2010) found a tendential
increase in plasma OT in response to the Trier Social Stress Test (TSST) and an inverse
relationship between OT and salivary cortisol levels. However, others have failed to find a
significant OT response to the TSST or modified versions thereof (Altemus, Redwine, Leong,
Frye, Porges, & Carter,2001; Heinrichs, Meinlschmidt, Neumann, Wagner, Kirschbaum, Ehlert,
et al., 2001) ; Cyranowski et al, 2008). These results suggest that the relationship between OT
and psychosocial stress should be further investigated.

Oxytocin in DPD
Although oxytocin levels have never been measured in DPD patients, several
factors suggest oxytocin levels may be elevated in depersonalization disorder patients:
1.

OT administration has inhibited amygdala activity suggesting that the
decreased amygdala activity found in DPD patients may be due to
elevated OT levels.

2.

Elevated cortisol levels in DPD may be associated with elevated OT levels
since cortisol administration has been shown to increase oxytocin levels.
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3.

Elevated levels of OT are found in depressed and anxious patients
suggesting that DPD patients may also have elevated OT levels given high
comorbidity with mood and anxiety disorders.

4.

A recent study found that persons with higher levels of dissociation also
have elevated OT levels.

Thus, OT levels should be investigated in DPD patients. If DPD patients have increased
OT levels, effective regulation of OT may help ameliorate symptoms of emotional numbness,
anxiety, and depression and facilitate better social cohesiveness in DPD individuals.

Conclusions
Depersonalization disorder (DPD), is an often debilitating psychiatric disorder
characterized both by feelings of detachment from the self or others as well as emotional
blunting or numbness. Subjective and physiological evidence of decreased emotional arousal
may suggest impaired emotion regulation abilities. Deficits in emotional processing of DPD have
been associated with dysregulated cortisol levels and may also involve dysregulated oxytocin
levels. In this series of studies, we aimed to investigate the physiological correlates of emotion
regulation in depersonalization disorder. To that end, we used self-report and physiological
measures to assess how effective DPD patients are at regulating their emotions. We also
investigated the relationship between changes in oxytocin and cortisol in the stress response of
DPD patients. Further elucidation of the neural and chemical mechanisms which underlie
detachment and emotional blunting in DPD will improve our ability to develop therapeutic
treatments that ameliorate these symptoms.
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CHAPTER ONE
Aim I: Investigation of ability of DPD patients to subjectively down-regulate and upregulate pleasant and unpleasant emotions.
Evidence suggests impairment in emotional processing for DPD patients. DPD patients
show high levels of alexithymia and often experience emotional blunting (a dampening of the
emotional experience) or numbness as well as an emotional disconnection from their loved ones
(Sierra and Berrios, 2001), both delineating a dysfunctional experience of emotion. DPD
patients have also expressed feeling less aroused by unpleasant pictures (Sierra, Senior, Dalton,
McDonough, Bond, et al.,2002) and have rated emotional pictures as less intense (Sierra, Senior,
Phillips, & David, 2006; Phillips, Medford, Senior, Bullmore, Suckling, et al., 2001) than healthy
controls and anxiety groups, indicating a decreased magnitude of emotions. This propensity for
decreased emotionality and arousal in DPD may suggest a relative inability to up-regulate
emotion but an enhanced capacity to down-regulate emotion. However to date, no studies in the
literature have investigated the ability of DPD patients to modulate their response to emotional
stimuli. In this study, DPD patients and a normal control group used reappraisal, an antecedentfocused emotion regulation strategy, to up-regulate or down-regulate their emotional response to
pleasant and unpleasant pictures. Participants then reported the emotional salience (how pleasant
or unpleasant the picture was), emotional arousal, and dominance (how controlled by or in
control of the situation in the picture the person felt) of each picture.

Hypothesis: Given their propensity for decreased emotional responsivity, we
hypothesized that DPD patients would be better at down-regulating and worse at upregulating emotion to both unpleasant and pleasant stimuli than the control group.
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Main finding: Compared to the control group, the DPD group was better at downregulating emotional salience and dominance for unpleasant pictures. However, for
arousal ratings, DPD patients were less aroused by the pictures overall, and less able to
modulate arousal levels.

Methods
Participants
Participants were 16 dissociative disorder patients recruited via self-referral and 15 age
and gender-matched normal controls. Diagnosis of dissociative disorders was established using
the Structured Clinical Interview for Dissociative Disorders (SCID-D-R; Steinberg, 1994).
Participants with diagnoses of substance abuse, schizophrenia, eating disorders, severe
depression, suicidality, as well as history of head trauma were excluded. Fifteen dissociative
disorder patients met diagnostic criteria for DPD while one participant met criteria for
Dissociative Disorder NOS (not otherwise specified). DPD participants taking psychotropic
medications were not excluded. The control group was recruited from the undergraduate
Psychology 100 course population at Hunter College of the City University of New York and via
craigslist.com advertising. Participants in the control group were prescreened using the
Dissociative Experiences Scale (DES; Carlson & Putnam, 1993), Center for Epidemiologic
Studies Depression Scale (CES-D; Radloff, 1977), and the State/Trait Anxiety Inventory-Y2
(STAI; Spielberger, 1983). Control participants with total scores above 12 on the DES
depersonalization subscale (DES_DPS) and DES amnesia subscale (DES_AMN), 14 on the
CES-D, and 44 on the STAI-Y2 were excluded.
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The study was conducted at Hunter College and approved by the Institutional Review
Boards of Beth Israel Medical Center, New York and City University of New York Hunter
College. All participants gave written informed consent prior to study participation. Participants
in the control group received $30 compensation.

Measures
The Dissociative Experiences Scale (DES : Carlson & Putnam, 1993) is a 28-item
questionnaire used to measure the frequency of dissociative experiences on a 0% to 100% scale
in 10% increments. Sound psychometric properties of the DES have been established (van
IJzendoorn and Schuengel, 1996). A factor analysis extracted a 3 factor solution comprising of
Amnesia: associated with dissociative identity disorder; Absorption: associated with the
propensity to daydream or fantasize; and Depersonalization/derealization (Ross et al., 1991).
The items of these 3 factors have since been classified as the DES subscales: Amnesia (DESAMN), Absorption (DES-ABS) and Depersonalization/derealization (DES-DPS). These
subscales are purported to represent, not only the 3 factors of dissociation, but have been
proposed to represent 3 distinct constructs themselves.
The Center for Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977) is a 20item self-report questionnaire commonly used to screen for symptoms of depression in the
general population. Respondents report the incidence of items on a 4-point scale from 0, rarely or
none of the time (less than 1 day” to 3, most or all of the time (5-7 days). The measure has high
internal consistency and adequate test-retest reliability given it measures state levels of
depression. Although a cut-off score of 16 is standardly used to delineate a depressive syndrome,
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in the current study, a more conservative cut-off score of 14 was used to screen control
participants.
The State/Trait Anxiety Inventory-Y2 (STAI; Spielberger, 1983) is 40-item questionnaire
that assesses state (STAI-Y1) and trait (STAI-Y2) levels of nervousness and anxiety. The STAIY1 and STAI-Y2 versions comprise of 20 items each and have been demonstrated to have good
test-retest reliability and internal consistency. Given that Spielberger found a mean score of
34.89 for working adults with a standard deviation of 9.19, we used a cut off score of 44 to
screen control participants.
The Cambridge Depersonalization Scale (CDS : Sierra & Berrios, 1996) is a 29-item selfreport questionnaire which assesses the frequency and duration of symptoms of
depersonalization experienced in the last 6 months. Frequency is reported on a 5-point scale
(anchors: 0= never; 4 = all the time), and duration is reported on a 6 point scale (anchors: 1= few
seconds; 6 = more than a week). The test has very good internal consistency (Cronbach’s alpha =
0.89) and is able to differentiate DPD patients from other patient groups and healthy controls.
The Childhood Trauma Questionnaire-Short Form (CTQ: Bernstein & Fink, 1997) is a
28-item self-report scale used to gage childhood and adolescent experiences of interpersonal
trauma. Items are rated on a 5-point, Likert-type scale ranging from Never True to Very Often
True. Clinical subscales of the CTQ include physical abuse, sexual abuse, emotional abuse,
physical neglect, and emotional neglect.
The Toronto Alexithymia Scale (TAS: Bagby, Parker, & Taylor, 1994) -20 is a 20-item
self-report scale which measures alexithymia. Respondents indicate on a 5-point scale the degree
to which each item applies to them (anchors: 1 = strongly disagree; 5 = strongly agree). Three
subscales have been derived from the TAS-20: Difficulty Describing Feelings, Difficulty
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Identifying Feelings, and Externally Oriented Thinking, The TAS-20 has demonstrated good
internal consistency (Cronbach’s alpha = .81) and test-retest reliability ( .77).
The Emotion Regulation Questionnaire (ERQ; Gross & John, 2003) asks respondents to
report their use of reappraisal and suppression strategies to regulate positive and negative
emotion. The scale is comprised of 10 items which are each rated on a scale from 1 (strongly
disagree) to 7 (strongly agree). Results of exploratory factor analysis indicate the measure
comprises of two factors: a suppression factor and a reappraisal factor. Items of these factors
form the suppression and reappraisal subscales of the ERQ. Cronbach’s alpha for the Reappraisal
and Suppression subscales is .79 and .73 respectively and the test-retest reliability is .69.
The Peritraumatic Dissociative Experiences Questionnaire (PDEQ: Marmar, Weiss, &
Metzler, 1997) is an 8-item questionnaire used to measure immediate dissociation at the time an
event is occurring. Respondents indicate the degree to which they experienced each item on a
Likert scale (1 = not at all true, 2 = somewhat true, 3 = definitely true). The PDEQ has
demonstrated adequate test–retest reliability and internal consistency (Birmes, Brunet, Benoit,
Defer, hatton, Sztulman, et al., 2005). In the current study, instructions were modified to read
“Please rate the following statements based on your experience right now, at this moment” for
the version given just prior to administration of the emotion regulation task, and “during the task
you just completed” for versions given during and directly following the emotion regulation task.
The Positive and Negative Affect Scale (PANAS; Watson, Clark, & Tellegen, 1998) is a
20-item self-report measure that assesses subjective distress and unpleasurable engagement
(negative affect) and pleasurable engagement (positive affect) on a 5-point likert scale from 1
(very slightly or not at all) to 5 (extremely). The positive affect and negative affect subscales
comprise 10-items each and have shown high internal consistency and good test-retest reliability.

26

Two versions of the PANAS were administered: the PANAS-now asked respondents to indicate
‘to what extent you feel this way right now, that is, at the present moment” while the PANASpast week asked respondents to indicate ‘to what extent you felt this way during the past week.”
Beck Depression Inventory-II (BDI-II; Beck et al., 1996) is a 21-item self-report scale
that assesses severity depression symptomology. Each item contains four possible statements
related to a given emotion (e.g., sadness, guilty feelings, and agitation) that are rated from 0 to 3.
The questionnaire asks respondents to choose the statement that most accurately describes how
they have been feeling over the past two weeks. Item responses are summed yielding a total
score from 0 to 63.
The Self-Assessment Manikin (SAM; Lang et al., 1999) is a self-report measure
assessing subjective valence, arousal, and dominance. The SAM comprises 9 graphical figures
for each of 3 scales: emotional salience (ranging from 1, extremely unpleasant to 9, extremely
pleasant), arousal (ranging from 1, extremely calm to 9, extremely aroused), and dominance
(ranging from 1, completely controlled to 9, completely in control). Respondents choose the
figure that best represents their response.
Stimulus. Stimuli consisted of 280 pictures from the International Affective Picture
System (IAPS, Lang, Bradley, & Cuthbert, 2009; 120 pleasant, 120 unpleasant, 40 neutral).
Results of analyses of variance (ANOVA) using ratings assessed by Lang et al. indicated all
picture types differed significantly in ratings of valence (emotional salience; F 2,277 = 10523.96, p
<.001; pleasant pictures: M= 7.34 , SD= 0.26; unpleasant pictures: M = 2.34; SD = 0.26; neutral
pictures: M= 5.00; SD = 0.30), arousal (F 2,277 = 115.44, p <.001; pleasant pictures: M=4.98,
SD= 0.97; unpleasant pictures: M = 5.77; SD = 0.70; neutral pictures: M= 3.42; SD = 0.89), and
dominance (F 2,277 = 655.29, p <.001; pleasant pictures: M= 6.03, SD= 0.53; unpleasant pictures:
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M = 3.63; SD = 0.55; neutral pictures: M= 5.78; SD = 0.51) Pictures were presented on a 17”
computer monitor.
Emotion regulation task. Instructions for the emotion regulation task were the same as for
Moser et al. (2006). Briefly, participants were instructed to either enhance (increase the intensity
of the emotion felt in response to the picture), suppress (decrease the intensity of the emotion felt
in response to the picture) or view the picture as they normally would. To avoid confusion of
enhancing or suppressing a nonexistent emotion, participants were only instructed to view
neutral pictures. The instruction (“Enhance,” “Suppress,” or “View”) was presented on screen
for 2000 ms. Then a blank screen appeared for 500 ms followed by 5 pictures for 2000 ms each
with an interstimulus interval of 1500 ms that also consisted of a blank screen. Each condition
contained 40 pictures. Half of the pictures were presented before a questionnaire break and the
other half after the questionnaire break. All pictures of a condition were presented in succession.
Presentation of conditions was randomized.
Ratings. Following the emotion regulation task, participants were interviewed and asked
to indicate the strategies they used during the task to regulate their emotions to pleasant and
unpleasant pictures on a 5-point scale (0, “never, ” 1, “rarely,” 2, “50/50.” 3, “mostly,” and 4,
“always”). Strategies were “shifting attention to another part of the picture,” “focusing on
physical experience,” “increasing or decreasing breathing,” “tightening muscles,” “moving the
face,” “closing eyes or looking away,” and “thinking of other things not in the picture.” All
pictures were then re-presented for 2000 ms in random order and participants rated their
emotional salience, arousal, and dominance using the SAM directly following each picture
presentation.
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Procedure
Participants signed a consent form and completed the demographic questionnaire, BDI,
STAI-Y2, PANAS-past week, DES, CDS, CTQ, TAS, and ERQ. Participants then completed the
PDEQ, STAI-Y1, and PANAS-now. They then began the first half of the emotion regulation task
which included the 7 conditions with 20 pictures each. Participants then completed the PDEQ,
STAI-Y1, and the PANAS-now in order to assess changes in state levels of emotion and
dissociation during the task. They then underwent the second half of the emotion regulation task
consisting of the 7 conditions with different pictures. Participants again completed the PDEQ,
STAI-Y1, and the PANAS-now. At the end, an interview was conducted to assess the emotion
regulation strategies they used. Finally, participants were re-presented the pictures and rated
them using the SAM.

Statistical Analyses
Independent t-test and chi square statistics were used to analyze group differences in
demographic and clinical characteristics. For the emotion regulation conditions, an ability score
was calculated to indicate each individual’s ability to regulate emotion to pleasant and
unpleasant pictures. Ability to enhance was calculated by subtracting mean values of the view
conditions from mean values of the enhance conditions. Ability to suppress was calculated by
subtracting mean values of the suppress condition from mean values of the view conditions.
Thus, greater positive scores represent a greater ability to enhance or suppress emotion
respectively.
For picture ratings irrespective of emotion regulation instruction, an RM-ANOVA was
calculated for valence (pleasant, unpleasant, neutral) X rating type (emotion, arousal,
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dominance) X group (DPD, control). For picture ratings of each SAM subcategory during the
view condition, RM-ANOVA was also calculated for valence (pleasant, unpleasant, neutral) X
presentation (1, 2) X group. For picture ratings of each SAM subcategory of ability scores, RMANOVA was calculated for valence (pleasant, unpleasant) X presentation (1, 2) X instruction
(enhance, suppress) X group. For state questionnaires completed before, during, and after the
emotion regulation task, a RM ANOVA for time (before, during, after) X group (DPD, control)
for each questionnaire. Greenhouse-Geisser correction was used for P-values associated with
multiple degrees of freedom RM ANOVAs. Post-hoc analyses included RM-ANOVAs,
Bonferroni correction, 2-way ANOVA’s, independent and paired t-tests.

Results
Demographics and clinical characteristics
Table 1 presents the demographic and clinical characteristics of the sample. There were
no significant differences between the groups for age, gender, income, marital status, or
education. The control group was more ethnically diverse (t 29 = 3.050, p < 0.05), comprising of
6 African Americans, 2 Asians, 4 Hispanics, and 3 Caucasians compared to the DPD group, who
were all Caucasian except one participant `who identified as multi-racial. The DPD group
scored higher on the DES-total, DES-AMN, DES-DPS, DES-ABS, CDS, BDI, STAI-Y2,
PANAS-past week (positive & negative), TAS-total, TAS-difficulty describing feelings, and
TAS-difficulty identifying feelings (all p’s < 0.05). Although the groups did not differ in total
score on the CTQ, the DPD group scored higher on the emotional neglect subscale but lower on
the physical abuse subscale of the questionnaire (p’s < .05). There was a trend difference for the

30

ERQ Reappraisal and Suppression scales with the DPD group endorsing less reappraisal
strategies and more suppression strategies (p’s < .10).

Emotion Regulation Task Questionnaires
Figure 1 presents results of the questionnaires completed before, during, and after the
emotion regulation task. For the PDEQ, there was an overall group difference in dissociation
throughout the task (F 1,29 = 26.510, p < .001). T-tests indicated that the DPD group was more
dissociated before (t 22.844 = -5.177, p < .001), during ( t 29 = -2.984, p < .01), and after ( t 22.230 =
-4.361, p < .001) the task. For the STAI-Y1, there was a main effect for time (F 2,58 = 5.295, p <
.01). Pairwise comparisons indicated anxiety before the task (M = 33.94, SD = 11.59) was lower
than during (M = 37.97, SD = 12.77) and after (M = 38.45, SD = 12.84) the task. There was also
a main effect for group (F1,29=12.804, p < .005). The DPD group was more anxious before (t
19.919 = -4.459, p < .001), during (t 29 = -2.597, p < .05), and after the task (t 29 = -2.901, p <
.01). For the PANAS-positive now questionnaire, there was a main effect for group (F 1,28 =
294.190, p < .001). Compared to the control group, the DPD group reported less positive affect
before, and after the task. During the task, the groups differed in positive affect at the level of a
trend. There was also group X PANAS-positive now interaction at the level of a trend (F 1.56,43.67
= 2.697, p = .09; Greenhouse Geisser Epsilon=.78). For the PANAS-negative now questionnaire,
there was a main effect for group (F 1,28 = 7.774, p < .01). The DPD group reported more
negative affect before and during the task.

Picture Ratings
View Condition
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Emotional Salience. For the view condition of emotional salience, there was a main effect
for valence ( F 1.15,32.08 = 136.98, p <.001, Greenhouse Geisser Epsilon= .57). Unpleasant pictures
(M = 2.89, SD = 0.96) were rated less pleasant than neutral (M = 5.09, SD = 0.44) pictures and
pleasant (M = 6.43, SD = 0.85) pictures were rated more pleasantly than neutral pictures. There
was also a valence X group interaction (F 1.15,32.08 = 4.643, p < .05, Greenhouse Geisser Epsilon=
.57); the control group rated pleasant pictures more pleasantly (M = 6.86, SD = .86) than the
DPD group (M = 6.01, SD = .83), t 27.975 = 2.739, p < .05.
Arousal. For arousal, there was a main effect for valence (F 1.42,39.80 = 10.021, p < .005,
Greenhouse Geisser Epsilon= .71). Neutral (M = 3.60, SD = 1.45) pictures were less arousing
than pleasant (M = 4.47, SD = 1.79) and unpleasant (M = 4.81, SD = 1.70) pictures. There was
also a trend toward a group effect (F 1,28 = 3.37, p = .08). Overall, the DPD group rated pictures
as less arousing (M = 3.83, SD = 1.97) than the control group (M = 4.76, SD = 1.97).
Exploratory tests revealed that compared to the control group, DPD patients tended toward rating
neural and pleasant pictures as less arousing (neural pictures: t 28 = 1.78, p = .09; pleasant
pictures: t 28 = 1.91, p = .07).
Dominance. For Dominance, there was a main effect for valence F 1.43,40.01 = 36.10, p <
.001, Greenhouse Geisser Epsilon= .72) Participants indicated feeling less in control for
unpleasant (M = 4.28, SD = 1.85) pictures than neutral (M = 5.83, SD = 1.63) and pleasant (M =
6.20, SD = 1.40) pictures. There was a also a valence X group interaction at the level of a trend (
F 1.43,40.01 = 3.12, p = .07, Greenhouse Geisser Epsilon= .72). The DPD group tended toward
rating pleasant pictures as less dominant (M = 5.62, SD = 1.44) compared to the control group
(M = 6.77, SD = 1.36) (t 28 = 2.24, p < .05).
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Emotion Regulation Conditions
Emotional Salience. For ability to modulate emotional salience, there was a main effect
for group (F 1,28 = 4.471, p <.05). Overall, the DPD group was better at regulating emotion (M =
.043, SD = 0.13) than control group (M = -.023, SD = 0.11),. There was also a valence X
instruction X group effect (F 1,28 = 4.377, p < .05), reflecting that the DPD group tended to
better suppress emotion to unpleasant pictures (M = .12, SD = .33) compared to the control
group (M = -.08, SD = .25), t28 = -1.929, p=.06 (see Figure 2A).
Arousal. For ability to modulate arousal, there was a trend toward a main effect for group
(F 1,28 = 3.35, p =.08). The DPD group was less able to modulate arousal levels (M = -0.05, SD =
.14) than controls (M = .04, SD = .21; see Figure 2B). There were no interaction effects.
Dominance. For ability to modulate subjective dominance, there was a trend toward an
instruction X group effect (F 1,28 = 3.07, p < .10), reflecting that the DPD group tended to be
better able to suppress loss of control during unpleasant pictures (M = .10, SD = .28) compared
to the control group (M = -.11, SD = .36), t 28 = -1.78, p = .09 (see Figure 2C).

Emotion Regulation Strategies
The groups showed differences in emotion regulation strategies used during the task.
Compared to the control group, the DPD group reported they focused more on their physical
experience during pleasant (X2 4 = 14.29, p < .01) and unpleasant (X2 3 = 10.19, p < .05)
pictures, and varied their breathing less during unpleasant pictures at the level of a trend (X2 3 =
6.92, p = .08).
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Discussion
In this experiment, we investigated the ability of DPD patients to subjectively regulate
emotion. During the task, DPD patients presented with more anxiety and had less positive affect
and more negative affect than the control group. For the view condition, the DPD group rated
pleasant pictures as less pleasant, tended to feel less in control during pleasant scenes, and tended
to rate neutral and pleasant pictures as less arousing than the control group.
For pictures that were emotionally regulated, overall, DPD patients were better than the
control group at regulating emotional salience, a result which was driven by the DPD group’s
tendency to be better at suppressing unpleasant emotion. Compared to the control group, the
DPD group tended to modulate arousal less effectively. The DPD group also tended toward a
better ability to suppress feeling less in control of unpleasant scenes than the control group.
Differences in emotion regulation strategies were also found. Compared to control group,
DPD patients reported a tendency toward less use of reappraisal strategies and more use of
suppression in emotional situations. For the Regulation task, DPD patients focused on their
physical experience more for both pleasant and unpleasant pictures and tended to alter their
breathing less than the control group.
The tendency of DPD patients to rate pictures as less arousing during the view condition
is consistent with previous findings (Sierra et al., 2002). Correspondingly, DPD patients also
have decreased skin conductance (Sierra et al., 2002; 2006) and limbic activity (Phillips et al.,
2001; Lemche et al., 2008) in response to viewing emotional stimuli. Decreased subjective
arousal may, therefore, be due to dysfunction of the limbic system in DPD.
The tendency of DPD patients to rate pleasant pictures as less pleasant is also consistent
with previous findings in which DPD patients rated unpleasant stimuli as less intense (Sierra et
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al., 2006; Phillips et al., 2001). However, we did not find differences between the groups in
emotional salience for unpleasant pictures. Discrepancies between findings for pleasant and
unpleasant pictures may be related to differences in stimuli arousal levels. Sierra hypothesized
that evaluation of emotional intensity may be, in part, dependent upon a stimulus’ representation
of autonomic arousal, and therefore, evaluation of emotional intensity may also be dysfunctional
in DPD due to decreased limbic activity. It should be noted that the current study employed
pleasant pictures with lower standardized arousal ratings than unpleasant pictures as assessed by
Lang et al. (2009). Thus, under high arousal circumstances, DPD patients may experience
sufficient arousal levels and can accurately discern emotional salience. However, when stimuli
are less arousing, DPD patients may find emotional stimuli less intense (i. e., interpret pleasant
pictures as less pleasurable).
A superior ability to regulate emotion in DPD was driven by a trend significant ability of
DPD patients to suppress emotion to unpleasant pictures. DPD patients also tended toward a
better ability to suppress feelings of loss of control when viewing unpleasant pictures.
Correspondingly, DPD patients reported a tendency to use more emotional suppression and less
reappraisal.
Taken together, these results suggest that at the heart of depersonalization is pervasive
emotional suppression. DPD patients report higher rates of childhood interpersonal trauma
(Simeon et al., 2001). Frequent exposure to negative events in childhood may lead young DPD
individuals to develop a pattern of withdraw from negative emotion or emotional avoidance. A
depersonalized child may, therefore, not feel associated feelings of helplessness and loss of
control that a highly traumatized child may feel. Hence, as adults, DPD patients generally feel
less. This constant pattern of withdrawal and avoidance may also make it difficult for DPD
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patients to modulate arousal, as demonstrated. Already low arousal levels would be difficult to
lower further while a persistent pattern of emotional suppression would impede arousal
enhancement. Thus, DPD patients might feel stuck in a pattern of emotional numbness.

Conclusion
Consistent with previous findings, we found that DPD patients rated emotional pictures
as less arousing and less emotionally salient. However, to our knowledge, intentional modulation
of emotion has never been investigated in DPD. We found that during active emotion regulation,
DPD patients demonstrate a pattern of decreased positive emotionality and arousal as well as a
pervasive suppression of negative emotion. Study 2 will investigate the relationship between
subjective suppression during emotion regulation in depersonalization and corresponding
physiological responsivity.
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CHAPTER TWO
Aim II. Physiological Evidence for Impaired Emotion Regulation in Depersonalization
Disorder
Corresponding with reports of hypoemotionality and hypoarousal in DPD, physiological
measures indicate a decrease in neural response while viewing emotional stimuli: lower
amplitudes in skin conductance response were found for unpleasant pictures and disgusted faces
in DPD groups compared to control and anxiety groups (Sierra et al., 2002; 2006). Early case
studies have also indicated decreases in skin conductance that corresponded to symptoms of
depersonalization (Lader and Wing, 1966; Lader, 1975). Experiment 1 demonstrated that
consistent with subjective reports of decreased emotionality in previous studies, DPD patients
also demonstrate difficulties in subjectively enhancing emotion but a superior ability to suppress
emotion. In this study, we aim to determine if impaired emotion regulation in DPD corresponds
with physiological responses. In this study, DPD patients and a normal control group used a
response-focused emotion regulation strategy, to up-regulate, or down-regulate their emotional
response to pleasant and unpleasant pictures while skin conductance response and heart rate were
measured. Participants then reported the valence (emotional salience, arousal, and dominance of
each picture.

Hypothesis: We expected increased ability to suppress emotion subjectively would
correspond with better ability to suppress emotion physiologically as measured by heart
rate and skin conductance.

Main finding: For emotional salience, while control participants were better at
subjectively modulating unpleasant emotion than pleasant emotion, the DPD group
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showed no differences. However, heart rate measures indicated that compared to the
control group, DPD patients were better at suppressing but worse at enhancing emotion
(see below publication: Monde, Ketay, Giesbrecht, Braun, & Simeon, 2013 Reprinted
with permission from Elsevier Inc).
Introduction
Depersonalization Disorder (DPD) is characterized by feelings of detachment from one’s
mental processes or body (American Psychiatric Association, DSM IV-TR, 2000) and associated
childhood interpersonal trauma, most notably emotional maltreatment (Simeon et al., 2001),
alexithymia (Simeon et al., 2009), and emotional numbing (Simeon et al., 2008). DPD patients
exhibit decreased skin conductance responses (SCR) to viewing emotional pictures (Sierra et al.,
2002) and a differential time course of SCR during an emotional video viewing (Giesbrecht et
al., 2010) compared to healthy controls. The hypoemotionality of DPD is associated with
prefrontal cortex hyperactivation and limbic hypoactivation on fMRI (Lemche et al., 2007). This
altered emotional responsiveness suggests that depersonalization may involve an impaired ability
to upregulate emotion, a hypothesis previously untested. In the present study, physiologic and
subjective ratings were recorded while DPD participants and controls modulated their response
to emotional pictures. We hypothesized that individuals with depersonalization would have
difficulty enhancing, but would be better at suppressing, emotion irrespective of stimulus
valence.
Method
Subjects
Diagnosis was established using the Structured Clinical Interview for Dissociative
Disorders-Revised (Steinberg, 1994). Participants also completed the Toronto Alexithymia Scale
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(TAS; Bagby et al., 1994), Childhood Trauma Questionnaire (CTQ; Bernstein et al., 2003), Beck
Anxiety Inventory (BAI; Beck and Steer, 1993), Beck Depression Inventory-II (BDI; Beck et al.,
1996) and Cambridge Depersonalization Scale (CDS; Sierra and Berrios, 1996). Individuals with
lifetime schizophrenia or bipolar disorder, and current major depression, eating disorder, or
substance use , as well as major medical conditionswere excluded. The study was approved by
the Mount Sinai School of Medicine and all participants gave written informed consent.
Emotion regulation task
Stimuli were 49 pictures from the International Affective Pictures System (IAPS; Lang et
al., 1999; 21 pleasant, 21 unpleasant, 7 neutral). The IAPS characterizes pictures in terms of
valence and arousal, which is in line with the circumplex model of affect (Russell and Barrett,
1999). Pleasant and unpleasant pictures were equivalent in arousal, but different in valence.
Stimuli were not chosen to represent specific emotions and were presented once for 12s each on
a 15-inch computer screen in randomized order. A cue was presented for 4s followed by picture
onset. A verbal instruction was presented 4s post picture onset. Consistent with Jackson et al.
(2000) participants were instructed to enhance (increase the intensity of the emotion they feel),
suppress (decrease the intensity of the emotion they feel), or maintain their emotional response to
pleasant and unpleasant pictures, while for neutral pictures only the maintain instruction was
given. No specific instructions were provided for heart rate (HR) or SCR. Participants were free
to choose their regulation strategy but instructed not to think about things unrelated to the scene
depicted. A blank screen was displayed for 12s following picture offset. Participants then rated
the picture’s valence using the 9-point Self Assessment Manikin scale (Lang et al., 1999).
Finally, the word “Relax” appeared onscreen for 20s.
Skin Conductance and Heart Rate Measurement
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SCR and HR were measured with two BioPac EL507 Disposable Electrodermal
Electrodes that were filled with isotonic gel and placed on the middle phalanx of middle and ring
finger of the non-dominant hand (Fowles et al., 1981). Before electrodes were attached,
participants rinsed their hands with distilled water. SCR was recorded using a BioPac GSR100C
with gain of 5 μS/ V and a low-pass filter at 10 Hz. HR was recorded using a BioPac PPG100C
coupled to a photoelectric pulse transducer (TSD200). Signals were sampled at 200 Hz by a
BIOPAC MP150 (Biopac Systems, Goleta, CA) system connected to a data-acquisition computer
running the Acknowledge v3.8.2 software package. For HR and SCR,levels in the 4s preceding
the emotion regulation instruction (resting level) and the 8s following the instruction were
averaged for each condition. These bins were then transformed by subtracting the average resting
level from the subsequent instruction.

Calculation of Ability Scores
We a priori operationalized that a superior ability to enhance emotion would be
demonstrated by an increase in score on physiologic and subjective measures of emotion
compared to the maintain condition. Conversely, a superior ability to suppress would be
demonstrated by a decrease in these scores compared to the maintain condition. Therefore, we
calculated an ability score reflecting each individual’s capacity to regulate emotion in response
to pleasant and unpleasant pictures using mean values for each measure (Enhance
Ability=Enhance - Maintain; Suppress Ability=Maintain - Suppress). Thus, negative ability
values represent an inability to regulate emotion as instructed.
Statistical Analyses
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Independent t-test and chi square statistics were used to analyze group differences in
demographic and clinical characteristics. For subjective ratings, SCR, and HR separately, a 3
(valence) * 2 (group) Repeated Measures Analysis of Variance (RM-ANOVA) was conducted
for the maintain condition, and a 2 (valence) * 2 (enhance/suppress instruction) * 2 (group) RMANOVA was calculated for ability scores. Mann-Whitney U and paired t-tests were used for post
hoc analyses. Pearson’s correlations and partial correlations controlling for depression and
anxiety separately were performed between descriptive and outcome variables for the combined
sample and between ability scores for each group.

Results
Sample Characteristics
Demographic and clinical characteristics (mean ± SD) for the 14 DPD (4 women) and 14
healthy control (5 women) participants respectively were: Age: 30.8 ±7.2 vs. 31.3 ± 11.9;
Education (years): 16.6 ±2.5 vs. 16.4 ±2.1; CDS: 144.4 ±49.9 vs. 12.6 ±13.8; BDI: 25.0 ±9.8 vs.
2.9 ±3.2; BAI: 20.3 ±13.4 vs. 2.8 ±3.0; TAS: 43.1 ±17.9 vs 33.2 ±10.7; CTQ: 43.1 ± 17.9 vs.
33.2 ± 10.7. Six DPD participants were taking psychotropic medications: sertraline, venlafaxine
(n=2), quetiapine plus ramelteon, tranylcypromine, and donepezil plus lamotrigine. Three
patients met current criteria for Dysthymia, 2 for Panic Disorder, 2 for Social Anxiety Disorder,
1 for Generalized AnxietyDisorder, 1 for Hypochondriasis, 1 for Body Dysmorphic Disorder,
and 1 for Anxiety Disorder, NOS. Comorbidities for 3 patients were missing. Age of onset of
DPD was 16.6±2.5 years, with a duration of 128.3±33.0 months. The groups did not significantly
differ in age, gender, or education. The DPD group tended toward a higher score on the CTQ (P
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= 0.09) and its emotional abuse subscale compared to controls: (10.2 ±6.2 vs 6.6 ±2.9, t = -1.95,
P=0.07). The DPD group scored significantly higher on all other questionnaires (P’s <0.001).
Group Comparisons
Maintain Condition. For subjective ratings, a significant main effect for valence was
found (F1.385, 36.003 =64.81, P < 0.001): pleasant pictures were rated as more pleasant than neutral
pictures, while unpleasant pictures were rated as more unpleasant than neutral pictures (P’s <
0.001). There was also a trend group effect for valence ( F1,26 = 3.25, P = 0.083), as DPD
participants tended to rate pictures more negatively than controls . For SCR, a significant main
effect for valence was found (F2,50 = 4.844, P < 0.05), reflecting increased SCR for emotional
compared to neutral pictures (P < 0.025). No significant effects were found for HR.
Emotion Regulation Ability. For subjective ratings, there was a significant main effect for
valence (F1,26 =17.30, P <0.001) indicating all participants were better able to subjectively
regulate their response to unpleasant compared to pleasant pictures. There was also a significant
instruction x valence interaction (F1,26 = 6.00, P =0.02), indicating all participants were more
able to enhance emotion to unpleasant compared to pleasant pictures. Finally there was a
marginal group x valence interaction (F1,26 = 4.21, P = 0.050; Figure 3A), as controls were better
at modulating emotion to unpleasant than pleasant stimuli (paired t=3.19, P = 0.004) while the
DPD group showed no valence difference.
For HR, there was a significant group X instruction interaction (F1,25 = 4.56, P = 0.03;
Figure 3B): compared to controls, DPD participants had a lesser ability to enhance (U = 246.00,
P < 0.05) and a greater ability to suppress (U = 234.50, P < 0.05) emotion irrespective of
valence. There were no significant findings for SCR.
Correlations
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Ability to subjectively enhance unpleasant emotion was negatively correlated with
depersonalization (r=-0.42, P=0.03) and alexithymia (r=-0.46, P=0.01). Ability to subjectively
suppress pleasant emotion was positively correlated with childhood trauma (r= 0.55, P=0.003).
After controlling for anxiety, the above-mentioned correlations remained intact. After controlling
for depression, only the positive correlation between ability to subjectively suppress pleasant
emotion and childhood trauma was unaffected (r= 0.58, P=0.002). In addition, alexithymia was
negatively correlated with ability to suppress positive emotions via HR (r= -0.44, P=0.03).
For the DPD group, there was a positive correlation between HR and ratings for ability to
enhance unpleasant emotion (r= 0.555, P=0.04). For the control group, there was a positive
correlation between HR and SCR for ability to suppress pleasant emotion (r= 0.661, P=0.01).
After controlling for anxiety and depression, the above-mentioned correlations remained intact.
All other correlations were non-significant.

Discussion
To our knowledge, this is the first study examining emotion regulation in
depersonalization disorder. As predicted, DPD participants exhibited an impaired ability to
enhance and a heightened ability to suppress emotion (as indicated by HR). This was further
supported by a positive association between HR and ratings for ability to enhance unpleasant
emotion, indicating a direct and dynamic relationship between subjective emotion regulation and
physiologic responsivity in DPD. Consistent with the hypoemotionality reported in the
disorder,the inability to feel an emotion would make it impossible to increase the emotion
whereas the act of suppression could employ a strategy of emotional withdrawal, resulting in
reduced physiologic responsivity typical of depersonalization.
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Additionally, the negative association between ability to enhance unpleasant emotion and
depersonalization, as measured by subjective ratings appeared to be mediated by depression
levels suggesting that the inability to subjectively upregulate unpleasant emotion seems to be due
to heighted levels of depression in DPD. Germane to this finding is a study by Ehring et al.
(2010) who found that recovered-depressed persons seem to employ emotional suppression more
often than the control group. The relationship between suppressing and enhancing emotion
should be further investigated.
The negative relationship between alexithymia and ability to subjectively enhance
unpleasant emotion or suppress HR response to positive emotion (when controlling for
depression) may imply that deficits in identifying emotion lead to impairments in regulating
them. While alexithymia is itself a construct distinct from depersonalization, alexithymia, and in
particular difficulties identifying emotion, are associated with depersonalization (Simeon et al,
2001) and may therefore contribute to the debilitating effects of the disorder.
Interestingly, childhood trauma was associated with suppression of positive emotion,
diverging from the alexithymia and depersonalization findings in its impact on emotion
regulation and warranting further assessment in future studies.
One important limitation of the study may lie in how we operationalized emotion
regulation ability as an outcome variable. Documented inconsistencies in the literature regarding
physiological responsivity both to emotional stimuli (see Kreibig, 2010 for review) as well as
instructions to modulate emotions (see Urry, 2009) indicated this is a broader problem within the
field which may be due to variations in methodology. While some studies diverge from our
findings, studies using similar design paradigms to ours have found analogous trends in HR,
SCR, and ratings in response to instruction to enhance and suppress emotion (Bernat et al., 2011;
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Urry, 2009). Correspondingly, the positive correlations we found between ability scores for some
emotion regulation conditions lend support for our operational definitions of emotion regulation
abilities for the three measures.
Findings of this study may have important treatment implications, such as utilizing
therapeutic interventions that emphasize experiencing, labeling, and communication of feelings
in order to more adaptively regulate emotion, that is, suppress less and enhance more. Studies
investigating emotion regulation strategies more comprehensively within larger non-medicated
samples and including depressive control participants are needed.
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CHAPTER THREE
Aim III: To Determine the Relationship between Cortisol and Oxytocin Responsivity to
Acute Psychosocial Stress in DPD
DPD patients have demonstrated dysregulated basal cortisol levels (Simeon et al., 2001;
Stanton et al., 2001; Simeon et al., 2007) and depersonalization has been associated with
differences in the cortisol surge under psychosocial stress (Simeon et al., 2007; Giesbrecht et al.,
2007). However, oxytocin levels have never been measured. Previous studies have shown that
cortisol administration is associated with increased OT levels (Tops et al., 2007; Tops et al.,
2012), and depression and anxiety tend to be associated with higher levels of OT (Parker et al.,
2010; Cyranowski et al., 2008) Additionally, a recent study demonstrated elevated OT levels in
hyperemesis gravidarum patients who presented with increased levels of dissociation (Seng et
al., 2013) suggesting that OT levels may be high in depersonalized patients. We investigated
emotion regulation and neurohormonal changes during acute psychosocial stress in DPD patients
and a normal control group. DPD patients and normal controls performed the Trier Social Stress
Test. Saliva samples were collected directly before, immediately following, and at 20 minutes
and 40 minutes post stress task completion, and oxytocin and cortisol levels were assessed.

Hypothesis: We predicted that consistent with previous studies, DPD patients would rate
the TSST as more stressful and have higher overall cortisol than a normal control group.
We also expected higher oxytocin levels for DPD patients than the control group.
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Main findings: The TSST induced subjective stress in the control group but not the
DPD group. Compared to the control group, the DPD group had higher overall levels of
cortisol and oxytocin.
Methods
Participants
Participants were 10 DPD patients and 15 normal controls recruited via craigslist.com.
Normal controls scored below 12 on the Beck Depression Inventory and Beck Anxiety Inventory
and below 10 on the Dissociative Experiences Scale. Diagnosis of dissociative disorders was
established using the Structured Clinical Interview for Dissociative Disorders (SCID-D-R;
Steinberg, 1994). Participants with diagnoses of substance abuse, schizophrenia, eating
disorders, severe depression, suicidality, as well as history of head trauma were excluded. Nine
dissociative disorder patients met diagnostic criteria for DPD while one participant met criteria
for Dissociative Disorder NOS (not otherwise specified). Five DPD participants were taking
welbutrin plus trazodone; lamictal, klonopin, welbutrin, EMSAM patch, plus topomax; synthroid
plus clomid; lexapro plus welbutrin; and lamictal, Zoloft, seroquel, plus klonopin. DPD patients
were compensated $50 and normal controls were compensated $30 for study participation.
Participants were instructed to refrain from eating, drinking and smoking for at least 1 hour prior
to study participation and to avoid alcohol consumption for at least 12 hours prior to arrival. Two
women were post-menopausal, and pre-menopausal women participated during the follicular
stage of their menstrual cycle. One woman was taking birth control.
Measures
Beck’s Anxiety Inventory (BAI: Beck, Epstein, Brown, & Steer, 1988) is a 21 item
measure that assesses severity of anxiety symptoms in the last week. Each item contains four
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possible statements related to a given symptom (e.g., unsteady, terrified, and numbness or
tingling) that are rated on a likert scale from 0-3. The BAI has shown high internal consistency (a
= .92) and test-retest reliability over 1 week, r (81) = .75).
The Relationship Scale Questionnaire (RSQ: Griffin & Bartholomew, 1994) is a 30 item
questionnaire that assesses orientation to relationships on a 7-point likert scale from 0, Not at All
to 6, Very Much. The RSQ contains 4 subscales: Secure scale, Fearful scale, Preoccupied scale,
and Dismissing scale.
The Difficulties in Emotion Regulation Scale (DERS; Gratz, & Roemer, 2004) is
comprised of 36 self-report questions which measure multiple aspects of emotional
dysregulation. The DERS yields a total score as well as scores for its 6 subscales: Nonacceptance of emotional responses (NONACCEPT), Difficulties engaging in goal directed
behaviour (GOALS ), Impulse control difficulties (IMPULSE), Lack of emotional awareness
(AWARE), Limited access to emotion regulation strategies (STRATEGIES), and Lack of
emotional clarity (CLARITY).
The Profile of Moods Scale – Short form (POMS-SF: McNair, Lorr, & Droppleman,
2003) measures state levels of various moods and is used to assess distress. The POMS-SF is
comprised of 37 self-report items and includes 5 subscales: depression, anger-hostility, tensionanxiety, vigor, and fatigue subscales. Internal consistency estimates (chronbach’s alpha) for the
POMS-SF subscale scores range from .76 to .95 (Curran, Andrykowski, & Studts, 1995).
Other questionnaires included the Dissociative Experiences Scale (DES), the Cambridge
Depersonalization Scale (CDS), the Childhood Trauma Questionnaire (CTQ), Beck’s Depression
Inventory (BDI), the Toronto Alexithymia Scale (TAS), the Emotion Regulation Questionnaire
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(ERQ), the Peritraumatic Dissociative Experiences Scale (PDEQ), and the Positive and Negative
Affect Scale (PANAS). See study 1 for full description of these questionnaires.

Trier Social Stress Test
The Trier Social Stress Test is a frequently used standardized stress task that comprises of
a preparatory phase of 5 minutes, followed by a mock job interview (5 min) and a mental
arithmetic task (5 min) in front of an audience (Kirschbaum et al., 1993. The TSST has been
shown to reliably increase subjective stress and salivary cortisol levels in participants. For the
TSST, the participant was lead to a room and introduced to the audience prior to the start of the
interview. The procedure of the interview was then explained and the participant was instructed
that the audience members were specially trained to monitor non-verbal behavior. The
participant was led away to another room to prepare for the interview. After 5 minutes
preparation period, the participant was brought back to the room of the audience to for the
interview. Once 5 minutes had passed, the participant was asked to count backward from 3,081.
Procedure
Figure 4 presents a timeline for the procedure of experiment 3. All experiments were
conducted between 12 and 5pm. Upon arrival, participants signed an informed consent and
completed a demographic qurestionnaire, the Dissociative Experiences Scale, The Cambridge
Depersonalization Scale, The Childhood Trauma Questionnaire, Beck’s Depression Inventory,
Beck’s Anxiety Inventory, the Toronto Alexithymia Scale, the Emotion Regulation
Questionnaire, the Difficulties in Emotion Regulation Questionnaire, and the Relationships Scale
Questionnaire. After rinsing their mouth, participant rested in an empty room alone for 10
minutes. After the rest period, participants completed the Peritraumatic Experiences
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Dissociative Experiences Questionnaire (PDEQ), the Positive and Negative Affect Scale
(PANAS), and the Profile of Mood States-short form (POMS-SF). Saliva samples were also
taken. Participants then underwent the TSST. Following the TSST, the participants completed
the subjective stress scale, the PDEQ, PANAS, and POMS-SF and a second saliva sample was
taken. State emotion questionnaires and saliva samples were taken again at 20 and 40 minutes
post TSST cessation. Participants were then debriefed and thanked for participation and
compensation was provided.
Enzyme Immunoassays
Saliva was vortexed and 1 mL was aliquoted. Aliquot and remaining saliva were then
stored at -80 degrees F. Oxytocin assay: 1 mL aliquot was thawed, and centrifuged at 25000 rpm
for 15 min. 0.8 mL was aliquoted and 0.8 mL of 0.1% trifluoroacetic acid (TFA; Fisher
Scientific, Waltham, MA) in water was added. Samples were centrifuged again at _25,000 rpm
for 15 minutes. Sep pak (200 mg, 3 mL; Thermo Scientific, Bellefonte, PA) columns were
equilibrated with 1mL acetylnitrile (Fisher Scientific, Waltham, MA) followed by 12 mL of
0.1% TFA in water. Supernatant was then added to the column and allowed to filter through. Sep
pak was then washed with 12 mL of 0.1% TFA in water. Waste was discarded. 3mL of 40%
TFA/ 60% acetylnitrile concentration was added to the sep pak to elute the oxytocin which was
collected in a 5mL falcon tube. Eluant was evaporated in a vacuum centrifuge and stored at -80
degrees F until assay. OT assay was performed using Enzo Life Sciences Kit (Lause,
Switzerland). Cortisol was assayed using Salimetrics protocol and ELISA kit (State College,
PA).
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Statistical Analyses
A “stress” score was created for each time point by calculating the average of the tensionanxiety and anger-hostility subscales of the POMS-SF. We conducted a 2 (Group: DPD vs.
Control) X 4 (Time: Pre-TSST, Post-TSST, TSST+20, TSST+40) repeated measures analysis of
variance (RM ANOVA) for the PDEQ, PANAS positive and negative subscales, POMSdepression subscales, and stress score. We also performed a 2 (Group: DPD vs Control) X 4
(Time: Pre-TSST, Post-TSST, TSST+20, TSST+40) repeated measures analysis of covariance
(RM ANCOVA) for oxytocin and cortisol levels controlling for age and gender. Post hoc tests
using Bonferroni correction and Wilcoxon Signed-ranks were performed.
We calculated the following subscales for the questionnaires: DES-depersonalization
(DES-DPS); DES-amnesia (DES-AMN) DES-absorption (DES-ABS), DES-taxon (DES-T),
CTQ-physical abuse (CTQ-pa), CTQ-physical neglect (CTQ-pn), CTQ-emotional abuse (CTQea), CTQ-emotional neglect (CTQ-en), CTQ-sexual abuse (CTQ-sa), ERQ-suppression
strategies, ERQ-reappraisal strategies, DERS-non-acceptance of (the individual’s own)
emotional responses (DERS-Non-accept), DERS-difficulties engaging in goal-directed behavior
(DERS-Goals), DERS-impulse control difficulties (DERS-Impulse), DERS-lack of emotional
(self-) awareness (DERS-Aware), DERS-limited access to emotion regulation strategies (DERSStrategies), DERS-lack of emotional clarity (DERS-Clarity), RSQ-secure, RSQ-fearful, RSQpreoccupied, RSQ-dismissing,. Pearson’s product moment correlations were performed between
hormones, descriptive variables, and outcome variables for the combined sample.
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Results
Demographic and Clinical Characteristics
Table 2 presents demographics and clinical characteristics of the groups. No significant
differences were found between the groups for age, gender or marital status. The groups
significantly differed in ethnicity and the DPD group tended toward higher annual income than
control group. The DPD group scored higher on the DES and all subscales except for amnesia.
DPD patients also scored higher on the BAI, BDI, TAS total score, TAS-difficulty describing
feelings, TAS- difficulty identifying feelings, CTQ-total score, CTQ-emotional abuse subscale,
and CTQ emotional neglect subscale, RSQ-preoccupied subscale, and tended toward higher
scores for the DERS-goals and CTQ-sexual abuse. The control group scored higher on the BASfun seeking and RSQ secure relationship style.
Changes in Transient Dissociation
For the PDEQ, there was a main effect for time (F 2.20, 50.59 = 14.97, p < .001): transient
dissociation increased at the post-TSST time point, decreased by the TSST+20 time point, and
decreased further at TSST + 40 (Figure 5D). The DPD group showed more overall dissociation
than the control group (main effect for group: F 1, 23 = 8.77, p <.01). Finally, there was a group X
time interaction: F 2.20, 50.59 = 5.73, p < .01. For the control group, dissociation increased from
Pre-TSST to Post-TSST (Z = -3.19, p < .01), and then decreased from Post-TSST to TSST+20
minutes (Z = 3.09, p < .01) and from Post-TSST to TSST+40 minutes (Z = -3.19, p < .01).
However, no significant changes in dissociation were found in the DPD group (see Figure 5D).
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Thus, transient dissociation was higher in the DPD group than normal controls, and the TSST
induced dissociation in the control group but not the DPD group.
Changes in Emotion
For subjective stress (Figure 5E), there was a main effect for time (F 2.10, 48.35 = 7.18, p <
.05): subjective stress increased in response to the TSST and decreased between post-TSST and
TSST+20min as well as between post-TSST and TSST+40min. There was also a group X time
interaction (F 2.10, 48.35 = 4.13, p < .05): Although the same changes in stress found in the
combined group were found in the control group, the DPD group showed no changes in
subjective stress in response to the TSST. There was no group effect. (see Figure 5E). Thus, the
TSST induced stress in the control group but not DPD patients.
For the PANAS-positive affect (Figure 5A), there was a main effect for time (F 2.02, 46.63=
7.62, p < .01) : positive emotion decreased from Pre-TSST to TSST + 40 minutes, from PostTSST to TSST +20 minutes and from between Post-TSST to TSST+ 40 minutes. There was also
a time X group interaction: F 2.02, 46.63 = 3.66, p < .05). The control group showed a decrease in
positive emotion from Post-TSST to TSST+20 minutes (Z =-2.03, P < .05) from Post-TSST to
TSST+40 minutes (Z= -2.46, p < .05) as well as an overall decrease in positive emotion from
Pre-TSST to TSST + 40 minutes (Z = -3.18, p <.01). For the DPD group, positive emotion
decreased only from TSST+20 minutes to TSST+40 minutes (Z = -2.51, p < .05) and from PostTSST to TSST + 40 minutes (Z = -2.26, p <.05; see Figure 5). No main effect for group was
found for the PANAS-positive affect subscale. Hence, the TSST decreased positive emotion in
both groups, but for the DPD group, decrease in positive emotion occurred later.

53

For the PANAS-negative affect (Figure 5B), negative emotion decreased from PostTSST to TSST+ 40 minutes in the combined group (main effect for time: F 2.12, 48.65 = 3.45, p <
.05). There was also a time X group interaction. While negative mood did not change
significantly for the DPD group, for the control group, there was an increase in negative mood
from Pre-TSST to Post-TSST (Z = -3.30, p < .01) and a decrease from Post-TSST to TSST + 20
(Z= -3.21, p < .01), from TSST+ 20 to TSST +40 minutes (Z= -2.02, p < .05 ) and overall from
Post-TSST to TSST + 40 (Z = -3.31, p < .01; see Figure 5). No main effect for group was found.
In sum, negative mood increased in the control group while the DPD group showed no change in
negative emotion.
For depression (see Figure 5C), although there were no main effects for group or time,
we found a time X group interaction: F 1.65, 37.97 = 8.71, p < .01. Depression increased from PreTSST to Post-TSST (Z=-2.18, p < .05), then decreases from Post-TSST to TSST + 40 minutes in
the control group (Z=-2.11, p < .05). However, for the DPD group, depression decreased from
Pre-TSST to Post-TSST (Z=-2.49, p < .05) but increased from the Post-TSST to TSST+40
minute (Z=-2.05, p < .05). There was also an overall decrease in depression from the Pre-TSST
to TSST+40 minute for the DPD group (Z=-2.54, p < .05; see Figure 5). Thus, while the control
group showed an increase in depression in response to the TSST, the DPD group showed a
decrease.
Hormone Levels
Cortisol. There was a main effect for group: F 1,21 = 5.12, p = .034. The DPD group had
higher overall cortisol levels than the control group (see Figure 6A). There was also a main
effect for gender: F1,21=9.14, p=.006. Post-hoc Mann Whitney-U tests indicated that men had
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higher cortisol levels than women at all time points (see Figure 7). Finally, there was a time X
gender interaction: F1.97, 41.31=5.55, p= .008. For women, there were no significant main effects or
interactions. For men, there was a main effect for time (F 1.94, 27.11=11.54, p < .001): Cortisol
levels increased from Pre-TSST to Post-TSST and decreased from TSST+20 to TSST+40. There
was also a main effect for group (F1,14= 4.81, p = 0.05) : Men in the DPD group had higher
overall cortisol levels than men in the control group (see Figure 6B). Although there was no
group X time interaction for men, exploratory Mann Whitney U test indicated that compared to
men in the normal control group, men in the DPD group had higher cortisol levels at the PostTSST time point (Z = -2.06, p < .05).

Oxytocin. Oxytocin levels showed a marginally significant main effect for group: F1, 19 =
4.18, p=.055 with DPD patients tending toward higher OT levels than the control group (see
Figure 8A). There was also a trend toward a main effect for time: F3,57= 2.25, P=.09. Although
there was no group X time interaction, exploratory Wilcoxon signed-rank test indicated that for
the control group, Post-TSST levels of OT were significantly higher than Pre-OT levels ( Z = 2.103 p <.05) and OT at TSST+20 tended toward higher levels than Pre-TSST OT (Z = -1.92, p <
.06). No differences between OT levels of any time points for the DPD group were found. There
was a trend toward a main effect for gender: F 1,19 = 3.69, p=.07 (Figure 8B). Men tended toward
higher OT levels than women with men demonstrating trend significant higher OT levels than
women at the Post-TSST time point (Z = -1.34, p = .055; see Figure 9). As well, Post-TSST OT
levels were higher than Pre-TSST OT levels in men (Z = -2.16, p < .05) but not women (Z = 0.53, p > .05).
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Peak Hormone levels
When we compared OT levels between groups across the study, patients had a higher
peak oxytocin level than controls (mean=11.56 pg/mL SD= 4.57) and it occurred pre-TSST
while the control group had a peak oxytocin level (mean=7.64 pg/mL, SD = 3.45) which
occurred at TSST+40 (Z = 2.28, p < .05). In contrast, there were no differences between the
groups in peak cortisol levels.
However, we found sex differences in peak hormone levels. For women, the DPD group
tended toward higher peak OT levels (mean = 9.07 pg/mL, SD = 3.33) compared to the control
group (mean = 5.53 pg/mL, SD = 1.17) with peak OT levels in both groups occurring Pre-TSST
(Z=1.72, p <.09). For women, peak cortisol levels occurred Post-TSST, but no differences were
found between the groups for cortisol levels.
For men, the DPD group had higher peak OT levels (mean = 13.23 pg/mL, SD = 4.75)
compared to the control group (mean = 8.82 pg/mL, SD = 3.78; Z = 2.12, p < .05). In both
groups for men, peak OT levels occurred TSST+20. Men in the DPD group also tended toward
higher peak cortisol levels (mean =.59 ug/dL, SD= .33) compared to the control group (mean
=.35 ug/dL, mean = .08; Z=1.95, p=.05). In both groups for men, peak cortisol levels occurred
Post-TSST.
In sum, while the groups did not differ in peak cortisol levels for men and women
combined, peak oxytocin levels in DPD patients were higher and occurred earlier than the
control group. For women, peak OT levels occurred before stress induction, and female DPD
patients demonstrated higher peak OT levels than female control participants. For men, peak OT
levels occurred at TSST + 20 min with DPD men demonstrating higher peak OT levels than
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normal male controls. Peak cortisol levels in men and women occurred directly following the
TSST and tended to be higher in male DPD patients than normal male controls.
Correlations between Oxytocin and Cortisol
Table 3 presents correlations between oxytocin and cortisol for the combined control and
DPD patient group. For DPD patients and normal controls combined, cortisol decrease during
early stress recovery (Post-TSST – TSST+20) was positively correlated with OT decrease during
early stress recovery ( r = .568, p < .01) and decrease in OT during the total stress recovery
period (Post-TSST – TSST + 40; r = .573, p <.01). Oxytocin and cortisol showed no other
associations for the combined group. Interestingly, correlations between oxytocin and cortisol
differed between the groups. As presented in Table 4, for the control group, OT decrease during
early stress recovery was positively associated with post-TSST cortisol (r = .667, p < .01),
decrease in cortisol during early stress recovery (r = .607, p < .05), total cortisol stress recovery
(Post-TSST – TSST+20; r = .594, p < .05), as well as cortisol stress reactivity at the level of a
trend (r = .471, p = .08). In the control group, total OT stress recovery was also associated with
cortisol decrease during early stress recovery (r = .617, p < .05). However, Table 5 shows that
for the DPD group, only the association between decreased OT and cortisol during early stress
recovery was significant (r = .683, p < .05).

Correlations between Emotion and Hormone levels
As shown in Table 6, there were several associations between OT and emotionality.
There was a significant positive association between pre-stressor OT and lower levels of prestress positive affect and a trend significant positive association between pre-stressor OT and
pre-stressor levels of depression. Post-stressor OT was associated with general depression levels
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(BDI score), lower levels of pre-stressor positive affect, lower levels of post-stressor positive
affect, less post-TSST subjective stress, less increase in subjective stress during the TSST, and
less total decrease in depression and stress. There were no significant associations between
emotion and OT stress reactivity. However, OT decrease during early stress recovery was
associated with less decrease in depression over the total stress recovery period.
For cortisol, pre-TSST and post-TSST cortisol was associated with more decrease in
positive emotion during total stress recovery. Cortisol reactivity was associated with reduction in
positive emotion during the early recovery phase as well a decrease in positive emotion during
total stress recovery. Decrease in cortisol during early recovery was associated with less
decrease in depression during total recovery. Total cortisol recovery was associated with less
decrease in positive emotion under stress but more decrease in positive emotion during total
recovery. Cortisol reactivity was also positively associated with the emotion regulation strategy
of suppression, however, no relationship between the emotion regulation strategy of reappraisal
and hormone levels was found at any time point.

Correlations between Hormones, Dissociation and Childhood Trauma
Correlations presented in Table 7 control for general levels of depression (BDI score) and
anxiety (BAI score). Results in the combined sample demonstrate that higher levels of OT and
cortisol were positively related to dissociation. Specifically, pre-stressor transient dissociation
was associated with pre-stressor OT and less OT increase under stress. Post-stressor transient
dissociation was associated with less decrease in OT during early stress recovery as well as
during total stress recovery. For depersonalization score (DES-DPD), there was a trend toward
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lower decreases in OT during early stress recovery and higher cortisol levels pre- and post-TSST
as well as a trend toward higher cortisol stress reactivity.
Childhood trauma was also related to elevated hormone levels (see Table 7). Emotional
abuse was associated with higher pre-TSST OT levels as well as pre-TSST and post-TSST
cortisol levels. Physical neglect was associated with less decrease in cortisol during early stress
recovery.

Discussion
In this experiment, we investigated the relationship between salivary cortisol and
oxytocin levels of DPD patients and normal controls under acute social stress. We found that in
the combined group, decreases in oxytocin and cortisol were positively related during the first 20
minutes post stressor (early stress recovery). However, group differences for these hormones
were evident. Consistent with previous studies (Simeon et al, 2001; Simeon et al, 2007), DPD
patients showed higher cortisol levels than the control group. DPD patients also tended toward
higher OT levels than normal controls. For OT, peak levels were higher and occurred earlier for
the DPD group compared to normal controls. Additionally, for the control group, post-stress
cortisol levels were associated with a decrease in OT during early stress recovery. There was
also a trend significant positive association between cortisol reactivity and OT decrease during
early stress recovery. These associations were not present for DPD patients. Given that OT
administration has shown to decrease stress, these elevated levels in DPD may represent a
homeostatic mechanism to decrease stress by DPD patients. We further explore this hypothesis
in the final discussion section.
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Group differences were also evident for dissociation and subjective emotion. For the
control group, the TSST induced stress, dissociation depression, and negative emotion.
Compared to the control group, DPD patients showed elevated levels of depression, negative
emotion, and dissociation and tended toward higher levels of subjective stress and lower levels
of positive emotion. Additionally, DPD patients showed no changes in these emotional states
except for depression where instead of an increase in response to stress, DPD patients
demonstrated a decrease in depression. These results further demonstrate dysregulated subjective
emotion in DPD and may be related to the higher levels of alexithymia that DPD patients
experience. Difficulty in identifying and describing emotion may impede the ability of DPD
patients to recognize changes in emotion. As well, since elevated post-stress OT levels were
associated with alexithymia, dysregulated hormone levels may also be playing a role in
alexithymia in DPD.
Hormone levels were associated with dissociation in the combined group. Dissociation
and depersonalization were associated with high cortisol levels, and there was a trend significant
association between depersonalization severity and cortisol stress reactivity. These results are
consistent with previous studies that found higher cortisol levels in DPD patients compared to
controls (Simeon et al., 2001; Simeon et al.; 2007) as well as one study that demonstrated an
association between depersonalization and stress reactivity in undergraduates (Giesbrecht et al.,
2007). However, Simeon et al. (2007) found an inverse relationship between dissociation and
cortisol stress reactivity. All studies suggest dysregulated cortisol in DPD. Higher Pre-stress OT
and lower OT stress reactivity (increase in OT under stress) were related to pre-TSST levels of
dissociation. These results suggest that with high levels of dissociation, basal OT is also high
and that OT levels may not increase (but possibly decrease) under stress. However, we may
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consider that pre-stressor measures were all collected in a stressful context: All participants were
informed in the consent form that they would be speaking before a panel of judges. Thus,
measures may not represent a true baseline for DPD, and elevated OT levels in DPD patients
may be in anticipation of stress. Post-stress dissociation levels were associated with less OT
stress recovery suggesting that unlike non-dissociated participants, individuals more susceptible
to elevated dissociation under stress may present with elevated oxytocin levels after stress as
well.
It should be noted that all female participants were in either in the follicular phase of their
menstrual cycle or post-menopausal. Consistent with previous studies (Walder et al., 2012;
Kirshbaum et al., 1999), we found lower cortisol levels and a trend toward lower OT levels in
female participants than males, and males showed a cortisol response to the TSST while women
did not. This may suggest that higher estrogen levels during the follicular phase attenuate the
stress response in women as previous studies have shown (Lindheim, Legro, Morris, Wong,
Tran, Vijod, et al., 1994). As well, higher cortisol levels were found in male DPD patients
compared to male normal control participants, but female DPD patients and controls showed no
difference. Together, these results may indicate that DPD in men is associated with more
cortisol than non-depersonalized men while DPD in the follicular phase may not differ from nondepersonalized women in the follicular phase. However, the small sample of female participants
makes it difficult to draw definitive conclusions regarding hormone differences between female
DPD patients and normal controls. Future studies should investigate sex differences and
menstrual phase in relation to depersonalization symptomology.
For childhood trauma, emotional abuse was associated with elevated basal (pre-TSST)
OT levels as well as elevated pre- and post-stressor cortisol. These findings diverge from
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previous studies that demonstrated lower basal OT (Heim et al., 2009) and cortisol (Carpenter et
al., 2007) in individuals with a history of child abuse. These differences may also be related to
higher basal OT levels due to anticipatory stress as discussed above. Nonetheless, these
associations may represent a dysregulated hormonal response under stress in persons with a
trauma history.
Relationships between hormone levels and emotion were also found. Pre-stressor OT was
associated with lower pre-stress positive emotion and a trend toward higher pre-stress depression
while post-stressor OT was associated with higher levels of general depression and lower levels
of positive emotion. This is consistent with previous findings: Taylor et al (2006) also found that
OT was related to lower pre- and post-TSST positive emotion in older women. Positive mood
induction has also been shown to decrease OT levels (Turner et al., 2002). Although one study
found no association between peripheral OT levels and depression (Altemus et al., 2001), other
studies have also found a positive association between depression and oxytocin: Parker et al.
(2010) found evidence for elevated plasma OT in depressed patients while Cyranowski et al.
(2008) showed that depressed women had higher OT levels while recalling situations where they
felt love or infatuation. Additionally, OT administration has been shown to decrease depressive
symptoms in rats (Arletti & Bertolini, 1987). Therefore, higher OT levels in depression may
represent an endogenous compensatory mechanism whereby OT is released in an attempt to
counter feelings of dysphoria. Additionally the negative association between OT decrease during
early stress recovery and decrease in depression during stress recovery further suggests that
sustained elevated OT levels after stress are necessary to attenuate post-stress depression. Poststress OT was also associated with lower subjective stress levels post-stressor as well as less
increase in stress during the TSST. These results are consistent with findings for the anxiolytic
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effects of OT administration (Heinrichs et al., 2003). Taken together, these results suggest that
under stress, OT may play a role in attenuating negative emotion. We further elaborate on this
hypothesis in the final discussion section.
Conclusions
In this study, we show a distinctive relationship between cortisol and OT for the control
group: elevated cortisol after stress is associated with decreased OT during OT recovery. This
association was not found in DPD patients. Instead, post-stress dissociation was associated with
a lesser decrease in OT during stress recovery in the combined group as well as lower levels of
subjective stress reactivity in depersonalized individuals. DPD patients presented with elevated
cortisol and a tendency toward elevated OT levels. DPD patients also showed higher peak OT
levels which occurred earlier than the control group. The reported lower subjective stress but
measured higher levels of stress hormones demonstrate the physiological components of
emotional dyregulation in DPD. While Experiment 3 utilized a stranger-evoked performancebased stressor, in experiment 4 we investigated the relationship between stress and hormones
using a reflective stress task which asked participants to recall a personally relevant stressful
incident.
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CHAPTER FOUR
Aim IV: To Investigate Relationship between Cortisol, Oxytocin and Depersonalization
during a Personally Relevant Psychosocial Stressor
Experiment 3 demonstrated elevated cortisol and OT levels but no significant changes in
subjective stress in DPD patients. Depersonalization was also positively related to the increase in
cortisol in response to psychosocial stress in the combined group. However, there were several
limitations to Experiment 3. Anecdotally, some DPD patients reported that public speaking is not
stress-inducing. Some also indicated that engaging with others actually distracted them from
their depersonalization symptoms and made them feel more connected and in their bodies. Thus,
a stressor that is personally relevant may induce higher levels of subjective stress in
depersonalized individuals. As well, experiment 3 comprised of a small sample size: 10
depersonalized individuals and 15 normal controls. Experiment 4 addressed these limitations by
employing a larger sample of non-clinical undergraduate students with a wide range of levels of
dissociation who underwent a personally relevant social stressor.
For experiment 4, 55 undergraduate students from psychology 100 courses at Hunter
College underwent the “Stressful Event Speech,” a stressor which allows the subject to recall and
relive a personally relevant stressful event. Participants described a stressful interpersonal event
to an experimenter and then watched a video-recording of themselves recalling the event. Saliva
samples and subjective ratings were collected directly before, immediately following, and at 20
minutes and 40 minutes post stress task completion, and stress, cortisol, and oxytocin levels were
assessed.
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Hypothesis: We expected that subjective ratings of stress and cortisol and oxytocin levels
would increase in response to the stressor. We also expected that depersonalization would
be positively related to levels of subjective stress, cortisol, and oxytocin levels.

Main findings: There was a significant increase in subjective reports of stress and
depression as well as salivary cortisol levels directly following the stress task. The
cortisol surge inversely related to dissociation, and depersonalization was associated with
more decrease in OT under stress but less OT decrease during stress recovery. However,
depersonalization was associated with increased subjective stress for women in the luteal
phase only.

Methods

Participants
Participants were 55 undergraduate Psychology 100 students (21 females, 32 males,
mean age= 18, SD =4.15) who received research credit for participation. Six women were in the
follicular phase of the menstrual cycle, 12 were in the luteal phase, and 3 women did not report.
Average household income was $62,700. Thirty-one percent were Caucasian, 26% were Latino,
16% were Asian, 4% were African American, and 18% self-identified as “other.” Four women
were on birth control. Participants had been instructed to refrain from eating, drinking and
smoking for at least 1 hour prior to study participation. Demographic and clinical characteristics
are presented in Table 8. The study was approved by the Institutional Review Board of Hunter
College.
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Stressful Event Speech
The Stressful Event Speech (SES) involves describing a stressful interpersonal incident
while the speech is recorded and then watching the performance of the speech. Participants were
instructed as follows:
For this task, you will describe an interpersonal experience that you had that caused you
stress or anger (for instance, a conflict or argument with 1 or more people). You should
describe the setting leading up to the incident, describe the incident, explain how the
incident and the other person(s)'s responses made you feel, and describe your own
physical and behavioral response. After a 2 minute preparation period you will begin
describing the incident. Try to feel exactly how you felt during the incident and relive the
event.
After the 2 minute preparation period, participants were asked spend 3 minutes recounting the
stressful event while their speech was video-recorded. During the speech, the experimenter
maintained constant eye contact and nodded empathetically. Following the speech, participants
watched themselves giving the speech and were instructed to try to feel the same way they felt
when the incident first happened.

Procedure
Figure 10 presents the procedure for Experiment 4. All experiments occurred between 1 and
5pm except for 6 that occurred at 10 am. Upon arrival, participants signed an informed consent
and completed the following baseline questionnaires: a demographic questionnaire, the
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Dissociative Experiences Scale, The Cambridge Depersonalization Scale, The Childhood
Trauma Questionnaire, Beck’s Depression Inventory, Beck’s Anxiety Inventory, the Toronto
Alexithymia Scale, the Emotion Regulation Questionnaire, and the Relationships Scale
Questionnaire. Participants then rinsed their mouth and rested in an empty room alone for 10
minutes. Before the stress task (pre-SES) participants completed the peritraumatic Experiences
Dissociative Experiences Questionnaire (PEDQ), the Positive and Negative Affect Scale
(PANAS), and the Profile of Mood States-short form (POMS-SF) and saliva samples were taken.
Participants then underwent the SES. Participants completed the subjective stress scale, the
PDEQ, PANAS, and POMS-SF and a saliva sample was taken both immediately following
(post-SES) and 20 minutes after the SES ended (SES+20 min). Participants were then debriefed.
Saliva Collection and Hormone Assays
Saliva collection was performed using passive drool method. Saliva was frozen within 30
minutes of collection. On the day of extraction, samples were allowed to thaw at room
temperature for 1.5 hours. Saliva was spun at 25,000 rpm and .8 mL was aliquoted for extraction.
Extraction and OT assay was performed consistent with procedures in study 3. Samples were
refrozen for cortisol assay on a separate day which was also performed consistent with
procedures in study 3.
Statistical Analyses
Five extreme scores were converted to within 3 standard deviations above the mean and one
missing data point was replaced with the mean score. Two participants who had more than 1
extreme score or missing data point were excluded. State emotion levels were assessed using
PANAS positive and negative affect subscales, POMS-SF depression subscale, and a “stress”
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score which was calculated by averaging POMS-SF tension-anxiety and anger-hostility subscales
at each time point. Stress reactivity scores were calculated for stress score, negative affect,
transient dissociation, oxytocin, and cortisol levels (Post-SES – Pre-SES) and well as for positive
affect (pre-SES – post-SES). Stress recovery scores were calculated for all measures as post-SES
– SES+20 min. Total OT decrease was calculated as pre-SES OT levels – SES+20 OT levels.
We conducted RM-ANOVA’s for all state emotion questionnaires and hormone levels
assessed at the 3 time points (pre-SES, post-SES, SES+20 min). Pearson product moment
correlations were performed between hormone levels and emotion measures. We also performed
partial correlations controlling for anxiety (BAI score) and depression (BDI score) between
depersonalization measures and hormone levels.
Results
Changes in Subjective Emotionality
Figures 11 A-D present changes in subjective emotion for the group. Although negative
affect increased in response to the stressor and returned to baseline by + 20 min (main effect for
Time: F1.58, 80.49 = 13.11, p <.001), positive affect decreased in response to the SES and never
recovered (main effect for time: F2,104 =12.99, p <.001. The SES induced subjective stress which
returned to baseline by +20 min (stress main effect for time: F1.74, 90.34=11.62, p < .001).
Depression levels also increased in response to the SES and returned to baseline by SES + 20
(main effect for time: F2,102= 8.65, p <.001; data not shown). The SES also induced dissociation
in the group with levels of dissociation returning to baseline by +20 min (main effect for time:
F2, 104 = 6.35, p < .05).
Changes in Salivary Cortisol and Oxytocin Levels
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Figures 12 presents oxytocin and cortisol levels during the Stressful Event Speech.
Cortisol levels significantly changed in response to the SES (main effect for time: F2,104= 6.11,
P<.05). Cortisol levels increased under stress (paired t52=-2.05, p < .05) and decreased during
stress recovery (paired t52=3.72, p < .001). Oxytocin levels significantly decreased in response to
the SES (main effect for time: F1.63,44.12=6.92, p < .05) with a significant decrease in OT
occurring during stress recovery (paired t27=2.19, p<.05) and from the beginning to the end
(paired t27=4.60, p<.001).
We found no significant differences between men and women for cortisol and oxytocin
levels across the study. However, exploratory Mann Whitney U tests indicated that compared to
women in the luteal phase of the menstrual cycle, men tended toward higher Pre-SES OT levels
(Z=-1.89, p = .06; see Figure 14B) as well as higher Post-SES cortisol levels (Z = -1.86, p = .06;
see Figure 13B) and higher final cortisol levels (Z = 1.79, p = .07; see Figure 13B). Compared to
women in the luteal phase of the menstrual cycle, women in the follicular phase tended toward
higher OT levels at the Pre-SES time point (Z = -1.84, p = .07) and Post-SES time point (Z = 1.84, p = .07; see figure 14B). There were no significant differences in hormone levels between
women in the follicular phase and men.
Correlations between Oxytocin and Cortisol Levels
Post-stress cortisol levels were positively correlated with the stress recovery decrease in
OT (r=.445, p<.05) and the total OT decrease (r=.387, p < .05; data not shown). Total OT
decrease was also positively correlated with final cortisol levels (SES+20 min; r = .420, p < .05)
as well as cortisol stress reactivity at the level of a trend (r = .364, p = .06). Thus, higher cortisol
levels were associated with more decrease in OT with both hormones declining after stress.
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Sex differences for the relationship between cortisol and oxytocin were also found. In
men, Pre-SES cortisol levels were associated with less OT decrease during the stressor (r=-.766,
p < .01) and more OT decrease during stress recovery (r=.662, p < .05). For women, Post-SES
cortisol levels were associated with more OT decrease during stress recovery (r=.547, p < .05).
Correlations between Hormone levels and Emotionality
As shown in Table 9, several emotional states were related to levels of oxytocin. Pre-SES
OT levels were associated with lower negative affect and stress, as well as with a lesser decrease
in positive affect during stress recovery. Post-stressor OT levels were also related to less
decrease in positive affect during stress recovery period.
Decrease in OT during the stress recovery period was associated with greater decrease in
positive affect during the stress task and less decrease in positive affect during recovery.
Decrease in OT during stress recovery was also associated with less general use of emotion
regulation reappraisal strategies. Higher levels of pre-SES and SES+20 depression as well as
post-SES levels of stress were associated with less total decrease in OT.
For cortisol, only a negative relationship between post-stressor cortisol and reduced
positive affect during the task was significant suggesting that cortisol may not play as great a role
as OT in changes in emotion as related to reflection on past stressful interpersonal incidents.
Additionally, emotional suppression was positively correlated with cortisol stress reactivity, an
indication that emotional suppression facilitates an increased sympathetic nervous system
response.
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Correlations between Hormone levels, Dissociative Symptoms and History of Childhood Trauma
As shown in Table 10, dissociation, as measured by the DES total score, and
depersonalization, as measured by the DES-DPS score, follow a differential pattern of OT stress
responsivity. Depersonalization was negatively correlated with OT increase during the stressor
(OT stress reactivity), with post-SES OT levels, and with OT decrease during stress recovery.
Final transient dissociation levels (SES+20 min) were negatively correlated with pre-stressor
OT, post-stressor OT, decrease in OT during stress recovery, total OT decrease, as well as
cortisol levels at all time points.
The negative association between depersonalization and OT increase during the stressor
and negative relationship between depersonalization and OT decrease during recovery was
intriguing. We, therefore identified 9 highly depersonalized individuals who scored above a
cutoff score of 12 on the DES depersonalization subscale which was consistent with our cut off
score for control groups of previous experiments (mean depersonalization score= 23.70, SD =
7.58). We then conducted an RM ANOVA with the within variable of time (the 3 OT time
points) and between variable of depersonalization (4 “high depersonalized” individuals vs. 24
“low depersonalized”). There was an interaction between depersonalization and time: F 2, 53 =
4.40, p < .05. While low depersonalized individuals showed a consistent and significant gradual
decrease in OT, high depersonalized individuals demonstrated a significant sharp decrease in OT
during stressor followed by an increase during stress recovery which was non-significant (see
Figure 15).
The only significant correlations found for childhood trauma were negative associations
between sexual abuse and pre-SES and SES+20 cortisol levels.
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When we explored sex differences in the relationship between depersonalization and
hormones, we found an association between increase in subjective stress during the SES and
depersonalization for women in the luteal phase (r = .599, p = .04) but not women in the
follicular phase (r = .146, p = .78) or men ( r = .165, p = .37; data not shown). As well, men
demonstrated a negative correlation between depersonalization and total OT decrease (r=.689,
p=.03) while women showed no relationship between hormones and depersonalization (data not
shown.

Discussion
In this experiment, we further explored the interaction between oxytocin and cortisol as
they relate to subjective emotionality and depersonalization. For the SES, cortisol responded
immediately to the stressor: Cortisol increased during the stressor and returned to baseline levels
during the 20 minute recovery period. In contrast, oxytocin showed a more latent response,
demonstrated by a significant decrease in levels during stress recovery and between pre-SES and
final (SES+20 min) levels. Additionally, cortisol and changes in oxytocin levels were directly
related: Consistent with results of control group in experiment 3, post-SES cortisol levels and
cortisol stress reactivity were associated with decreases in OT. Germane to these results,
Pierrehumbert et al (2010) also found a decrease in OT in response to social stress as well as a
negative relationship between oxytocin and cortisol under stress. These findings demonstrate, not
only the responsiveness of OT system to stress, but that under stress, heightened cortisol may
trigger changes in the OT system function that lead to decreased peripheral OT levels. Possible
mechanisms for these changes are put forth in our final discussion.
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Oxytocin was also related to state levels of emotion. Interestingly, higher pre-stressor OT
levels were associated with less pre-stressor negative affect and stress. High pre-stressor OT as
well as post-stressor OT levels were also associated with less decrease in positive emotion during
the stress recovery period and may suggest that OT works to prevent diminished positive
emotion in emotionally challenging contexts. These results highlight the inverse relationship
between OT and negative emotion, further supporting previous evidence for OT as a “feel good”
hormone. Additionally, higher OT levels may predict resilience to emotional stress.
A greater decrease in OT across the study (Total OT decrease) was associated with less
post-stressor negative affect, stress, depression, and less increase in depression under stress.
These findings suggest that decreases in OT in response to stress may be adaptive, associated
with better relationship skills and somehow bestowing protective effects from negative affect
under stress. Moreover, less OT decrease in response to stress confers emotional dysregulation
and poor relationship coping skills.
OT levels may demonstrate a distinctive pattern for depression: increased depression
during the stressor (depression stress reactivity) was positively related to final OT levels
(SES+20 min) but negatively related to the total decrease in OT across the study. These results
suggest that for depressed persons who may not recover from stress-induced depression,
prolonged depression may be associated with higher OT levels. This is consistent with results of
experiment 3 in which depression was associated with higher OT levels and less decrease in OT
post-stress. Previous studies have demonstrated elevated levels of OT in depression in response
to emotional induction or stress (Parker et al, 2010; Cyranowski et al., 2008). This change may
indicate that depression facilitates an OT release in response to stress which persists during the
recovery period. Alternately, individuals who are susceptible to depression may have
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dysregulated OT metabolism. These hypotheses are further explained in the final discussion
section.
Interestingly, decrease in positive emotion during the stressor was associated with more
OT release during stress recovery and less post-stressor cortisol while decrease in positive
emotion during stress recovery was associated with less OT release during stress recovery.
Changes in positive mood during stress may be beneficial and lead to reduced physiological
stress. However, rumination after stress may be indicated by dysregulated OT activity.
Dissociation and depersonalization were related to oxytocin and cortisol. When
controlling for anxiety and depression, transient dissociation was associated with lower cortisol
levels at all 3 time points. These results are similar to those of Simeon et al (2007) who found an
inverse relationship between cortisol reactivity and dissociation, suggesting a dysregulated HPA
axis in depersonalization. Transient dissociation was also associated with lower pre- and postOT levels. When we controlled for anxiety and depression, both dissociation and
depersonalization were negatively associated with OT stress reactivity (OT increase under
stress). However, depersonalization, but not total dissociation, was negatively related to OT
recovery (decrease in OT post-stressor). Thus unlike our depression findings, a dysregulated OT
stress system for depersonalization may be associated with increased early OT metabolism
and/or decreased OT production in response to stress.
For this study, there were few associations between cortisol and emotion: post-stress
cortisol was negatively related to positive affect decrease under stress and cortisol reactivity was
positively related to emotional suppression. The relationship between cortisol and emotion may
therefore be more associated with energy levels. For instance, Gross’ (1998) found association
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between emotional suppression and increased heart rate, skin conductance, and temperature. Lam
et al (2009) also found that suppression predicted the cortisol surge in response to the Trier
Social Stress Test.
Consistent with previous studies (Salonia et al., 2005; Skukovski et al., 1989), women in
the follicular phase of the menstrual cycle tended toward higher OT levels (Pre-SES and PostSES OT) than women in the luteal phase. Additionally, men tended toward higher Pre-SES OT
levels and higher Post-SES cortisol and final cortisol levels than women in the luteal phase. We
also found an association between depersonalization and total OT decrease in men but not
women. However, the positive relationship between depersonalization and increase in subjective
stress during the SES was found in women in the luteal phase but not women in the follicular
phase or men suggesting that lower estrogen levels in the luteal phase may impart and emotional
vulnerability for women. These results further emphasize the importance of considering gender
differences and menstrual phase in clinical research.

Conclusions
Cortisol and OT show a clear association under stress with increased cortisol under stress
being related to decreased OT after stress. The OT system may be related to emotional changes
to stress: high OT prior to stress and OT decrease after stress may be protective against
emotional discord, but low OT release in response to stress may indicate emotional
dysregulation. Unlike experiment 3, dissociation was associated with lower levels of cortisol and
OT as well as OT decrease under stress, but less decrease in OT during stress recovery. Lesser
decrease in OT during stress recovery was also associated with self-reported emotional
dysregulation suggesting the failure to decrease OT after stress may be a key symptom of
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emotional dysregulation in DPD. For this task, depersonalization may be associated with lower
levels of post-stress OT and more OT decrease under stress but less OT decrease (perhaps even
OT increase) during stress recovery suggesting dysregulated stress response in the OT system for
depersonalization. These results expand previous observations of a dysregulated HPA axis in
depersonalization (Simeon et al., 2007) by providing preliminary evidence for a relationship
between cortisol, oxytocin, and depersonalization.
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CHAPTER FIVE
Final Discussion
In this series of studies, we investigated how depersonalization affects emotion regulation
in both a physiological and subjective context. Experiments 1 and 2 examined the ability of
DPD patients to modulate emotion to affective stimuli both subjectively (experiments1 and 2)
and physiologically as demonstrated by heart rate and skin conductance response (experiment 2).
The superior ability of DPD patients to subjectively suppress negative emotion that was
found in study 1 was also confirmed with physiological results of study 2: Heart rate
demonstrated a greater ability to suppress emotion but a lesser ability to enhance emotion in
DPD patients compared to a normal control group. This superior ability to suppress emotion
corresponds with the hypoemotionality reported by depersonalized individuals: Unlike skin
conductance response which appears to be governed only by the sympathetic nervous system and
represents changes in arousal, heart rate response has been indicated in both sympathetic and
parasympathetic nervous system functioning and may be associated with arousal as well as
emotional salience (see Lang et al., 1993 for review). Given that skin conductance response
yielded no differences between the groups, the sympathetic nervous system may not be
dysfunctional in depersonalized individuals. Thus, emotional suppression (and the inability to
enhance emotion) in DPD may be governed by a dysregulated parasympathetic nervous system.
Germane to this point, Phillips et al. (2001) found that compared to healthy control group, DPD
patients showed more limbic activity while viewing neutral pictures but more prefrontal cortex
activity and less limbic activity when viewing emotional pictures. Hence, during emotional
suppression, DPD patients may demonstrate increased activity in the prefrontal cortex.
However, during attempts to enhance emotion, the prefrontal cortex may not disengage, and the
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parasympathetic system may impede DPD patients’ ability to fully experience and then magnify
the emotion. Future studies should consider neurological assessments for DPD patients like
fMRI to determine if the prefrontal cortex is overactive while limbic areas are less active during
emotion regulation.
Inconsistent with the 1st study, we did not find a superior ability to subjectively suppress
unpleasant emotion (emotional salience) in the second. Instead, for study 2, controls showed a
better ability to modulate emotion to unpleasant pictures compared to pleasant pictures while
DPD patients showed no difference in subjective ability to regulate emotion. Discrepancies
between the results of the studies may be due to methodological differences. In experiment 1,
arousal levels for pleasant pictures were lower. More importantly, task design was different for
the two studies. In study 2, since picture ratings were done online directly following emotion
regulation, it may have been difficult for patients to switch from actively regulating the emotion
to the cognitive task of emotional assessment. Pictures in study 2 were presented for 12 seconds
whereas in study 1, pictures were only presented for 2 seconds. This longer exposure to
emotional pictures may have facilitated more withdrawal from the pictures and lead to less
variance in emotional ratings between conditions for the DPD group. On the other hand, as
picture ratings in study 3 were conducted at the end of the protocol, they may not fully reflect the
experience of the moment. Furthermore, an antecedent-focused emotion regulation strategy was
utilized in study 1 (instruction given before stimulus) while a response-focused emotion
regulation strategy was employed for in study 2. In accordance with our earlier speculation of
the top-down prefrontal inhibition of emotional responses in DPD, it might be that the
mechanism of suppression of subjective emotionality can be better implemented in anticipation
of an emotion but is less effective when the emotional experience is in process.
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Experiments 3 and 4 explored how stress affects subjective emotion as well as oxytocin
and cortisol levels in depersonalization. Oxytocin levels in both studies were similar and
consistent with salivary measurements in previous studies (Carter, Pournajafi-Nazarloo, Kramer,
Ziegler, White-Traut, Bello, et al., 2007). Another consistent finding across both studies was the
clear association between post-stressor cortisol and decrease in OT during stress recovery.
Similarly, Pierrehumbert et al. (2010) found an inverse relationship between cortisol and
oxytocin during stress, however, this study did not investigate the timing of this association. The
temporal relationship between increased cortisol and decreased oxytocin demonstrates not only
the responsiveness of OT system to stress, but that under stress, heightened cortisol may trigger
changes in the OT system function that lead to decreases in endogenous OT concentrations.
We propose two theories for this relationship: 1) Higher cortisol may facilitate OT
metabolism. This can be studied by using a fluorescent marker for OT receptors under Positron
emissions tomography scan while participants perform the stress task to determine changes in
receptor expression. Increased OT receptor proliferation could indicate OT is being metabolized
more quickly in response to stress. Conversely, a decrease in OT receptors could signal
dysfunction in the OT system in special populations. 2) Alternately, emotional stress could
hinder OT production. Assessment of higher post- vs. pre- stressor OT in cerebral spinal fluid
and periphery could demonstrate such changes. It is important to note, however, that oxytocin is
produced by several organs in the body in addition to the brain (Kiss and Mikkelsen, 2005). It
would, therefore, be difficult to determine if a decrease in peripheral OT were due solely to
decreases in CSF concentrations or brain structures.
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As demonstrated by study 3 but not study 4, oxytocin may increase in response to
psychosocial stress. In rats, increased OT in response to psychosocial stress has been shown to
correspond with OT release in the brain (Bosch et al., 2004; Engelmann et al., 2004). However,
OT increases under stress may be dependent on the type of stress experienced and the duration of
exposure to the stressor. Under social stress, OT may be working through two separate but
related systems. In one, biological stress may foster OT release. In another, emotional stress may
facilitate OT metabolism or hinder OT production (as described above). Performance-related
stress like the Trier Social Stress Test may encompass physiological demands of the “fight or
flight” system due to its social encounter. These physical demands may, therefore induce OT
release in an attempt to attenuate the stress. Indeed, the TSST is a demonstrated physical stressor,
shown to increase heart rate (Kirschbaum et al., 1993) and skin conductance (Jezova et al.,
2004). Additionally, during the TSST, participants change location several times as preparation,
speech and rest all take place in different rooms, and the stress task is performed standing up
with participants often moving or walking around. In contrast, the reflective stress experienced
by the SES may not be a physically demanding given that the encounter is only remembered and
not actually experienced. As well, unlike the TSST, participants in the SES remain seated in the
same room. It should be noted, however, that cortisol increased in response to both stressors
which suggests that assessment of changes in cortisol and oxytocin under stress as well as the
decrease in oxytocin post-stressor may convey more about the stress response than cortisol or
oxytocin alone. As well, the TSST is a 15 minute stressor while the SES lasts only 8 minutes. It
is also possible that lengthening the time frame for the SES may yield similar increases in OT
during the stressor as demonstrated by the TSST.
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In experiment 3, OT increased under stress and decreased post-stressor in the control
group but not the DPD group. Other studies have failed to show any changes in OT in response
to the TSST (Altemus et al, Taylor et al., 2006; Parker et al., 2010; Grewen and Light, 2010).
However, Pierrehumbert et al. (2009) demonstrated a tendential increase in OT under stress
followed by a significant decrease after stress in a combined sample of women with childhood
sexual abuse, cancer survivors, and normal control participants. Discrepancies in results may be
due to methodological differences in the timing of assessment of basal OT and post-TSST OT
levels as well as the population sampled. For instance, our results suggest populations with high
levels of depression, dissociation, or emotional dysregulation may demonstrate less OT decrease
after stress. Additionally, associations between post-stress cortisol and OT stress recovery were
only found for the recovery period occurring 20 minutes after the stressor ended and not later.
Longer recovery from the TSST did not reveal this association suggesting that OT’s reaction to
physiological stress may be immediate and cease quickly.
For both studies, subjective stress was associated with lower levels of OT: these
associations occur before the stressor for the SES and after the stressor for the TSST.
Discrepancies in the timing of these associations may also be due to differences in methodology.
For the TSST, pre-stressor levels may not represent a true baseline since participants were
informed of the nature of the stress task they would perform and therefore some participants may
have demonstrated elevated OT levels in anticipation of the task. The participants in our TSST
experiment represent a peculiarly heterogeneous sample-comprising of both DPD patients and
normal control participants. As well, both experiments involve a very small sample size: 25
participants for the first study and 30 participants for the 2nd. Nonetheless, this inverse
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relationship between OT and subjective stress is consistent with the finding for anxiolytic effects
of OT.
The relationship between OT and emotion is, however, very complex. In addition to
associations between OT and decreased stress, both studies also suggest that after stress, less
positive emotion is related to higher OT. This relationship was significant in experiment 3 and
tended toward significance in experiment 4. These results are consistent with Taylor et al. (2006)
who also found a negative association between positive emotion and pre-and post- stress OT
levels. Experiments 3 and 4 also demonstrated an association between depression and OT. In
experiment 3, general levels of depression and less decrease in depression after stress were
associated with elevated post-stressor OT levels while pre-stressor depression was associated
with pre-stressor OT at the level of a trend. In experiment 4, the increase in depression under
stress was associated with final OT levels and less total decrease in OT during the study while
general levels of depression were associated with final OT at the level of a trend. Although one
previous study found no relationship between OT levels and depression (Altemus et al, 2001), in
other studies, depressed participants presented with higher OT levels (Parker et al, 2010;
Cyranowski et al., 2008). Additionally, rat studies have indicated that OT attenuates depressive
symptoms (Arletti & Bertolini, 1987). Thus, elevated OT levels in depression may indicate an
endogenous reflexive mechanism of the hormonal stress response. Oxytocin may be released in
order to alleviate feelings of depression. Indeed, prairie voles exposed to chronic social isolation
demonstrated increased anhedonia as well as greater OT release after stress and were
characterized by a greater number of OT cells in the PVN (Grippo, et al., 2007). However,
endogenous OT release may not be sufficient in alleviating symptoms and depressed patients
may benefit from OT replacement. This relationship may also explain why high levels of OT can
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indicate elevated stress but that OT administration can also relieve stress. Very anxious and
depressed individuals may require more OT than their system normally produces.
The association between hormones and depersonalization differed in the 2 studies. In
experiment 3, DPD patients showed elevated OT and cortisol levels throughout, while in
experiment 4 depersonalization scores in the non-clinical sample of undergraduate students were
associated with less post-stress OT and greater decrease in OT during the stressor. However, in
both studies, depersonalization was associated with less decrease in OT during the 1st 20 minutes
of stress recovery. Previous studies have also been unclear with respect to hormone levels and
DPD. Two studies have demonstrated elevated basal cortisol levels in DPD (Simeon et al., 2001;
Simeon et al., 2007) while one found lower basal cortisol levels for DPD patients (Stanton et al.,
2001). Correspondingly, in another study depersonalization in a non-clinical sample of
undergraduates was associated with greater cortisol stress reactivity (Giesbrecht et al., 2007).
However, Simeon et al (2007) found no difference in cortisol stress reactivity between DPD
patients and healthy controls. It is important to note that depersonalization found in the general
population is often an indication of other conditions like anxiety or symptoms of psychosis and
may not represent depersonalization disorder as diagnosed via SCID-D. Thus, some differences
between studies 3 and 4 may be due to discrepancies in the characteristics of depersonalization
between the groups.
Differing results between previous studies in the literature may also be due to a failure to
account for sex differences. In our small sample of experiment 3, we found that male
participants had higher cortisol levels and tended toward higher OT levels than female
participants in the follicular phase. Additionally, male participants were more responsive to
stress than follicular-phased female participants. As well, male DPD patients showed higher
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cortisol levels than normal male control participants overall, however female DPD patients
female control participants did not differ in OT or cortisol levels. Additionally, our finding of
higher OT levels for women in the follicular phase than women in the luteal phase is consistent
with previous studies (Salonia et al.; Skukowski et al., 1089). As well, an association between
depersonalization and OT decrease was found in men while a positive relationship between
subjective stress reactivity and depersonalization was found in women in the luteal phase. These
findings suggest gonadal hormones may play a protective role in emotional responsivity. Thus,
future studies should consider sex differences and menstrual cycle phase of female participants.
Discrepancies between hormone results of experiment 3 and 4 may also be due to
methodological differences. Elevated cortisol levels in DPD in study 3 may be an indication of
anticipatory stress: Subjects were aware they would be performing a stress task. Higher
anticipatory stress in DPD compared to normal controls would be consistent with the elevated
anxiety and depression often reported with DPD. In contrast, for study 4 which comprised of a
non-clinical sample, there was no association between depersonalization and elevated cortisol
levels. Additionally, unlike the TSST, the SES may induce a weaker cortisol stress response in
depersonalized undergraduates due to differences in physiological demands and the shorter
duration of the SES.
The positive relationship between depersonalization and less OT decrease during early
recovery for both studies is intriguing. Exploratory analyses in study 4 indicated that in
depersonalized participants there was a dramatic and significant decrease in OT during the stress
but a pattern of increase in OT during early stress recovery. This result suggests that for
depersonalized individuals, a rapid metabolism or decreased production of OT is initiated during
emotional distress. However, this decrease in OT is not sustained leading to less decrease in OT
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for depersonalized individuals during stress recovery. This change may indicate dysfunction in
the OT system such as dysregulated OT production, metabolism, OT receptor proliferation or
mutations of the OT receptor. Thus, these physiological processes represent possible areas of
future investigation using brain imaging techniques for visualizing and quantifying the OT
system.
It is plausible that for experiment 4, the decrease in OT during stress demonstrated by
depersonalized participants may represent a pattern of emotional suppression or withdrawal
during distress. Correspondingly, DPD patients in study 3 did not report an increase in subjective
stress despite a clear cortisol stress reactivity. The dichotomy between subjective stress and the
physiological responsivity may be due to high levels of alexithymia in DPD. Alexithymia was
positively related to post-stress OT in study 3, further suggesting that emotional confusion in
DPD patients may in part be related to dyregulated OT. Furthermore, Study 4 demonstrated an
association between less decrease in OT during stress recovery and emotional dysregulation
suggesting less decrease in OT during stress recovery may be a biomarker for emotional and
relational distress. Hence, this lack of post-stressor OT decrease demonstrated by depersonalized
individuals in both experiments may be indicative of their emotional dysregulation. Thus, DPD
patients may benefit from better regulation of their OT system.
Our studies had several limitations. All studies involved very small sample sizes. Studies
1 through 3 included medicated patient populations. For study 3, all participants were aware of
the stress procedure. Study 4 utilized an undergraduate sample whose symptomology may not be
consistent with a patient population or healthy controls. Future studies should control for these
limitations and include appropriate depressed control subjects.
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In summary, we found that emotional induction (both by visual stimuli or a stress task)
engenders subjective and physiological emotional dysregulation in depersonalized individuals.
Our findings have several therapeutic implications. DPD patients may benefit from interventions
such as heart rate variability biofeedback to identify patterns of physiological suppression in
response to emotion. In conjunction with heart rate variability biofeedback, psychotherapeutic
interventions like Dialectic Behavioral Therapy could help DPD patients identify and
communicate their emotions and ultimately suppress less in order to feel safe enough to fully
engage in the emotional experience. DPD patients may also benefit from hormonal interventions
to better stabilize OT levels allowing for a deeper emotional experience.
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Table 1
Demographic and clinical characteristics for DPD Patients and Normal Controls
who performed Emotion Regulation Task 1 (without physiological measures)

Measure

DPD Patients
Mean (SD)

Controls
Mean (SD)

t (df)

P

Age
30.31 (10.77)
30.87 (9.46)
-0.15 (29)
ns
2
Gender (F/M)
4-Dec
3-Dec
ns
4/12
3/12
X (1)=0.11
2
Handedness (R/L/A)
13/2/1
13/1/1
ns
X (2)=0.30
2
Education
Median: BA
Median: HS
ns
X (1)=1.64
2
Marital Status
Mode: single
Mode: single
ns
X (3)=2.55
Income
61,154
45,583
1.04(23)
ns
2
Ethnicity
Mode: Caucasian Mode: African American
<.01
X (4)=20.99
DES-Total
26.85 (12.50)
7.02 (9.00)
-5.04(29)
<0.001
DES-AMN
7.40 (8.25)
1.89 (3.88)
-2.40(21.61)
<0.05
DES-ABS
28.83 (17.40)
9.58 (12.15)
-3.55(29)
<0.005
DES-DPS
40.73 (14.93)
1.22 (2.13)
-10.47(15.65)
<0.001
DES-Taxon
26.09 (10.75)
3.17 (4.65)
-7.79(20.70)
<0.001
CDS
128.31 (51.13)
13.67(20.78)
-8.27(20.08)
<0.001
CTQ-emotional abuse
10.56 (6.16)
8.27 (4.56)
-1.17(29)
ns
CTQ-emotional neglect
11.94 (5.45)
8.07 (3.79)
-2.28(29)
<.05
CTQ-physical abuse
5.25 (0.77)
6.93 (2.74)
2.36(16.10)
<.05
CTQ-physical neglect
5.69 (8.00)
6.13 (1.64)
0.21(29)
ns
CTQ-sexual abuse
6.25 (2.59)
5.80 (1.78)
-0.56(29)
ns
STAI-Y2
49.19 (9.83)
32.33(10.10)
-4.71(29)
<0.001
BDI
15.38 (9.80)
3.53 (3.85)
-4.48(19.78)
<0.001
PANAS-Past Week Positive
26.50 (10.29)
37.40 (6.95)
3.43(29)
<0.005
PANAS-Past Week Negative
24.31 (8.40)
13.20 (4.33)
-4.67(22.75)
<0.001
ERQ-Suppression
14.19 (5.91)
11.20 (2.96)
-1.80(22.36)
<0.10
ERQ-Reappraisal
26.81 (8.69)
32.40 (8.02)
1.86(29)
<0.10
TAS-Total
51.00 (15.87)
38.07 (12.49)
-2.51(29)
<0.05
TAS-difficulty describing
15.13 (5.45)
9.53 (4.56)
-3.09(29)
<.05
TAS-difficulty
identifying
19.31
(6.44) DES Amnesia
11.13subcale;
(5.76) DES-ABS: DES
-3.72(29)
<.05
DES:
Dissociative
Experiences Scale;
DES-AMN:
Absorption subcale;
DPS:
DES
Depersonalization
subscale;
CDS:
Cambridge
Depersonalization
Scale;
CTQ:
Childhood
Trauma
TAS-externally oriented
12.88 (4.92)
12.60 (3.00)
-0.19(25.00)
ns
Questionnaire; STAI-Y2: State-Trait Anxiety Inventory-general; BDI: Beck’s Depression Inventory; PANAS:
Positive and Negative Affect Scale; ERQ: Emotion Regulation Questionnaire; TAS: Toronto Alexithymia Scale.
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Table 2

6/4

10/5

DES: Dissociative Experiences Scale; DES-AMN: DES Amnesia subcale; DES-ABS: DES Absorption subcale;
DPS: DES Depersonalization subscale; CDS: Cambridge Depersonalization Scale; CTQ: Childhood Trauma
Questionnaire; BAI: Beck’s Anxiety Inventory; BDI: Beck’s Depression Inventory; RES: Relationship Scale
Questionnaire; ERQ: Emotion Regulation Questionnaire; DERS: Difficulties in Emotion Regulation; TAS: Toronto
Alexithymia Scale.
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Table 3
Correlations between Cortisol and Oxytocin for the Combined Group during the Trier Social
Stress Test (TSST)
Pre-TSST
OT

PostTSST OT

OT
Stress
Reactivity

Early OT
Stress
Recovery

OT Total
Stress
Recovery

Pre-TSST Cortisol

.250

.089

-.128

-.091

-.006

Post-TSST Cortisol

-.017

.031

.042

-.248

-.146

Cortisol Stress Reactivity

-.178

.102

.181

.066

.151

Measure

**

Early Cortisol Stress Recovery

.183

.244

-.024

.568

Cortisol Total Stress Recovery

-.013

.222

.134

.281

.573

**

.302

Note: †P<.10, ** P< .01, * P< .05. Stress Reactivity: Post-Stress – Pre-Stress measurement. Stress Recovery:
Post-Stress- TSST+ 20 measurement. Total Stress Recovery: Post-Stress – TSST + 40 measurement.
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Table 4
Correlations between Cortisol and Oxytocin for the Control Group during the Trier Social Stress
Test (TSST)
Measure
Pre-TSST Cortisol

Pre-TSST
OT

Post-TSST
OT

OT Stress
Reactivity

Early OT
Stress
Recovery

OT Total
Stress
Recovery

.176

.432

.185

.357

.316

**

.178

.667

.014

.064

.471†

.241

-.188

-.121

.607

*

.617

.020

.594

*

.382

Post-TSST Cortisol

-.114

.328

Cortisol Stress Reactivity

-.231

Early Cortisol Stress Recovery
Cortisol Total Stress Recovery

-.423
-.182

.030

.427
*

Note: †P<.10, ** P< .01, * P< .05. Stress Reactivity: Post-Stress – Pre-Stress measurement. Stress Recovery: PostStress- TSST+ 20 measurement. Total Stress Recovery: Post-Stress – TSST + 40 measurement.
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Table 5
Correlations between Cortisol and Oxytocin for DPD Group during the Trier Social Stress
Test (TSST)
Pre-TSST
OT

PostTSST OT

OT
Stress
Reactivity

Early OT
Stress
Recovery

OT Total
Stress
Recovery

Pre-TSST Cortisol

.104

-.180

-.184

-.281

-.303

Post-TSST Cortisol

-.123

-.079

.032

-.240

-.162

Cortisol Stress Reactivity

-.360

.045

.269

-.157

.018

.036

*

.492

Measure

Early Cortisol Stress Recovery
Cortisol Total Stress Recovery

.430

.509

.683

-.160
.258
.270
.091
.133
Note: †P<.10, ** P< .01, * P< .05. Stress Reactivity: Post-Stress – Pre-Stress measurement. Stress Recovery:
Post-Stress- TSST+ 20 measurement. Total Stress Recovery: Post-Stress – TSST + 40 measurement.
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93

Table 7
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Table 8
Descriptive Statistics and Clinical Characteristics for
Participants who underwent the SES in Experiment 4
Std.
Measure
Mean
Deviation
age
18
4.15
income
62727
59352
Mode:HS/GED
education
Mode: Caucasian
ethnicity
DES total score
14.7035
11.66832
DES_DPD
5.8176
9.20228
DES_Taxon
8.4670
11.13359
DES_AMN
5.4717
8.02891
DES_ABS
20.0472
15.15537
CDS total score
35.2830
26.79579
BDI Score
10.4717
8.52734
BAI Score
10.2075
8.62099
RSQ_SECURE
14.2642
3.82377
RSQ_FEARFUL
11.7547
5.10997
RSQ_PREOCCUPIED
14.4151
3.60787
RSQ_DISMISSING
17.9245
4.62788
DERS_NONACCEPTANCE 14.1509
5.62753
DERS_GOALS
16.4340
5.48953
DERS_IMPULSE
9.8679
4.45938
DERS_STRATEGIES
16.4528
6.79809
DERS_AWARENESS
15.2453
4.66536
DERS_CLARITY
10.9811
4.08322
CTQ total score
38.8868
13.20498
CTQ_physical abuse
6.8868
2.56200
CTQ_emotional abuse
9.5094
4.91318
CTQ_physical neglect
6.7358
1.98214
CTQ_sexual abuse
5.9057
2.93037
CTQ_emotional neglect
9.8491
4.76928
TAS total score
47.6981
11.06725
ERQ_Reappraisal
30.2642
7.01139
ERQ_Suppression
14.6415
5.16309
DES: Dissociative Experiences Scale; DES-AMN: DES Amnesia subcale; DES-ABS: DES
Absorption subcale; DPS: DES Depersonalization subscale; CDS: Cambridge Depersonalization
Scale; CTQ: Childhood Trauma Questionnaire; BAI: Beck’s Anxiety Inventory; BDI: Beck’s
Depression Inventory; RES: Relationship Scale Questionnaire; ERQ: Emotion Regulation
Questionnaire; DERS: Difficulties in Emotion Regulation; TAS: Toronto Alexithymia Scale.
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Table 9
Correlations between Hormone Levels and Emotion for Participants who Underwent the SES in Experiment 4
Pre-SES
OT

Post-SES
OT

SES+20
OT

BDI Score
BAI Score

.047
-.268

.169
-.055

.360 †
-.060

.163
.120

-.071
-.063

Reappraisal Strategy
Suppression
Strategy

-.150
-.010

-.259
-.044

.113
.096

-.228
-.139

-.100

-.185
-.193
-.033
-.157

Measure

OT Stress OT Stress Total OT
Reactivity Recovery Decrease

Cortisol
Cortisol
Stress
Stress
Reactivity Recovery

Pre-SES
Cortisol

Post-SES
Cortisol

SES+20
Cortisol

-.360†
-.284

.119
-.017

.091
-.058

.047
-.010

.107
-.049

.109
-.101

-.385 *
-.189

-.333†
-.124

-.134
-.040

-.168
.125

-.150
.035

-.121
.280 *

-.009
.141

-.050
-.022
-.125
-.043

.006
-.196
-.228
-.225

.083
-.306
-0.217
-.325†

-.024
.022
.007
-.020

.035
.002
-.033
-.035

-.015
.035
-.032
-.014

.039
.035
.054
.010

.093
.045
.119
.031

-.014
-.401

.082
-.034
-.048
-.088

.023
-.035
-.077
-.081

.077
-.038
-.012
-.059

.120
.073
.170
.036

Baseline

Emotion Regulation

Pre-SES

Positive Affect
Negative Affect
Depression
Stress

-.403 *
-.190
-.385 *

-.145
-.297
-.214
-.307

Positive Affect
Negative Affect
Depression
Stress

.063
-.315
-.069
-.301

-.092
-.142
-.017
-.222

-.062
-.013
.289
-.003

-.105
.116
-.007
-.030

.001
-.134
-.256
-.255

-.431 *
-.396 *

.026
.070
.069
-.008

Positive Affect
Negative Affect
Depression
Stress

-.225
-.242
-.046
-.064

-.327†
-.179
-.071
-.054

-.209
.007
.195
.141

-.216
-.032
-.089
-.062

-.214
-.217
-.242
-.197

-.055
-.328†
-.290
-.250

.100
.075
-.047
-.103

.190
-.051
-.119
-.209

.111
-.017
-.182
-.149

.150
-.127
-.031
-.188

.156
-.007
.156
-.087

Positive Affect
Negative Affect
Depression
Stress

.255
-.065
.082
-.083

.373
.099
.176
-.040

.105
.195

.390 *
-.001
-.141
-.161

.218
-.314

.430 *
.137

.313
.215
.106
-.005

-.398 *
-.271

-.248†
.091
.077
.009

-.316 *
-.062
-.033
-.094

-.246†
-.111
-.092
-.106

-.229
-.115
-.076
-.099

-.143
.061
.107
.021

Positive Affect
Negative Affect
Depression
Stress

-.529 **
-.187
-.041
-.324†

-.471 *
-.028
.070
-.232

-.296
-.021
.170
-.162

-.239
.167
.106
.030

-.407 *
.012
-.057
-.114

-.356†
-.223
-.254
-.240

.129
.020
.135
.072

.197
.001
.056
.070

.153
-.025
.072
.031

.137
.052
.014
.085

.080
.082
.077
.105

Post-SES

SES+20 min

SES Reactivity

SES Recovery

Note: †P<.10, ** P< .01, * P< .05
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Table 10
Correlations between Hormone Levels and Childhood Trauma and Dissociation during the SES in Experiment 4
Measure

Pre-SES

OT

Post-SES
OT

SES+20
OT

OT Stress OT Stress Total OT
Reactivity Recovery Decrease

Pre-SES
Cortisol

Post-SES
Cortisol

SES+20
Cortisol

Cortisol
Stress
Reactivity

Cortisol
Stress
Recovery

Total Dissociation

.026

-.289

.024

-.427*

-.351†

-.144

-.097

-.240

-.199

-.247

.186

Depersonalization

-.214

-.491*

.110

-.453*

-.592**

-.291

-.234

-.290

-.220

-.191

.093

Pre-SES Dissociation

-.080

-.172

-.178

-.113

-.049

-.146

-.092

-.235

-.249

-.251

.176

Post-SES Dissociation

-.245

-.331†

-.201

-.277

-.288

-.326

-.228

-.302

-.284

-.210

.137

Final SES Dissociation

-.448*

-.503**

-.186

-.300

-.459*

-.466*

-.401*

-.509**

-.488*

-.340†

.098

Dissociation Reactivity

-.196

-.224

-.087

-.207

-.261

-.236

-.171

-.152

-.125

-.048

.024

Dissociation Recovery
History of Childhood
Trauma
Physical Abuse

.078

.033

-.065

-.059

.044

.011

.062

.066

.069

.036

.065

-.209

-.169

-.047

.001

-.127

-.221

-.065

.010

-.056

.158

.156

.184

.160

.211

.263

.220

-.002

.109

.143

.017

.147

0.264†

Emotional Abuse

-.163

-.156

.002

-.086

-.199

-.218

-.027

.021

-.029

.141

.138

Sexual Abuse

-.256

-.267

-.126

-.122

-.214

-.192

-0.307*

-.258†

-.272*

-.076

-.052

Physical Neglect

-.104

-.034

.061

.093

-.044

-.210

.105

.074

-.003

.097

.183

-.172

-.066

.057

.033

.220

.105

Emotional Neglect
-.291
-.185
-.181
.029
-.076
Note: †P<.10, ** P< .01, * P< .05. Values for dissociation measures were covaried by BAI and BDI scores.
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Figure 1. Affect, Anxiety, and Dissociation Before, During, and After the Emotion Regulation
Task

†

** p < .001
* p < .05
† p <.10

The control group showed an increase in negative affect during the task (paired t14=-2.32, p<.05)
as well as an increase in anxiety during the task (paired t 14 = -2.30, p <.05) which failed to return
to baseline levels (paired t 14 = 2.17, p <.05). For the control group, there was also a difference in
positive affect before compared to during the task at the level of a trend (paired t 14 = 1.97, p =
.07).There were no changes in negative or positive affect, dissociation, or anxiety levels across
the task for the DPD group.
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Figure 2. Emotion Regulation Abilities for DPD patients and Normal Controls for Experiment 1
A.

B.

C.
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Figure 3. Ratings and Heart Rate Ability Scores for Emotion Regulation in Experiment 2.

HR Ability Scores (bps)

A.
4

Control Enhance

3

Control Suppress

2

DPD Enhance

1

DPD Suppress

0
-1
-2
-3
-4

Control

DPD
Group

B.

Rating Ability Scores

4

Control Pleasant
Control Unpleasant
DPD Pleasant
DPD Unpleasant

3
2
1
0
-1
-2
-3

Control

DPD
Group

Ability scores for HR and ratings: Enhance Ability=Enhance - Maintain; Suppress Ability=Maintain –
Suppress A. HR data indicated that the DPD Group had a lesser ability to increase and a greater

ability to decrease emotion. B. There was a trend of a group * valence interaction for rating
ability. (Reprinted with permission from Elsevier Inc/1600 John F Kennedy Boulevard Suite
1800 Philadelphia PA 19103-2879 USA).
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Figure 4. Experimental Procedure for Experiment 3.
Procedure: Trier Social Stress Test Experiment

Baseline
Questionnaires

10 minute rest

Mood Assessment
Questionnaires
& Saliva Sample

Trier Social Stress Test
TSST Procedure:
5 minute preparation
5 minute job interview
5 minute mental math
Mood Assessment
Questionnaires
& Saliva Sample
20 minute rest

Mood Assessment
Questionnaires
& Saliva Sample

20 minute rest

Mood Assessment
Questionnaires
& Saliva Sample
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Figure 5. Subjective Emotion During the Trier Social Stress Test in Experiment 3
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Figure 6. Cortisol Levels for the Trier Social Stress Test
A.

B.

*

Note: * p < .05. A.Cortisol Levels for the Trier Social Stress Test for DPD Patients and
Normal Controls. B. Cortisol Levels during the Trier Social Stress Test for Men and Women
Separately
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Figure 7. Gender Differences in Cortisol Levels During the Trier Social Stress Test

Note: * p < .05. ** p < .001
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Figure 8. Oxytocin Levels during the Trier Social Stress Test in DPD Patients and Normal
Controls
A.
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A. Oxytocin Levels for men and women combined. B. Oxytocin levels for Men and Women
Separately.
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Figure 9. Gender Differences in Oxytocin Levels

Note: † p < .10
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Figure 10. Experimental Procedure for the Stressful Event Speech in Experiment 4
Procedure: Stressful Event Speech
Baseline
Questionnaires
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& Saliva Sample

Stressful Event Speech
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Mood Assessment
Questionnaires
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108

Figure 11. Subjective Emotionality in Response to the Stressful Event Speech in Experiment 4

* p < .05; ** p < .001
_________________________________
Figure 11. Self-reported positive and negative affect, stress, and dissociation at 3 time points:
immediately before, directly following and 20 minutes post SES. The SES significantly induced
stress and dissociation and increased negative affect, all of which returned to baseline by 20
minutes post stressor. The SES also significantly decreased levels of positive affect which did
not return to baseline.
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Figure 12. Hormonal Response to Stressful Event Speech
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Figure 12. Salivary cortisol levels at 3 time points: before, directly following, and 20 minutes
post SES. A. Cortisol increased under stress and returned to baseline by SES + 20. B. Oxytocin
decreased significantly after the stressor and was significantly lower than oxytocin levels before
the stressor.
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Figure 13.
A.

B.
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Figure 14.
A.

B.
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Figure 15. Comparison between High and Low Depersonalized Participants in the Stressful
Event Speech Experiment 4

Low-depersonalized individuals showed significant decrease in OT during stress recovery
(paired t 24 = 3.05, p < .05) and a significant total decrease in OT between pre-stress and final OT
measurement (paired t 24 = 5.71, p < .001). High-depersonalized individuals showed significant
decrease in OT during the stress task (paired t 4 = 4.73, p < .05) and a non-significant pattern of
increase during stress recovery ( paired t 4 = -2.32, p = .10).
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